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ABBREVIATIONS 
 
aa  - amino acid 
 
AC  - astrocyte 
 
Bcl6  - B-cell lymphoma 6 protein 
 
Bcor  - Bcl6 corepressor 
 
bFGF  - basic Fibroblast growth factor 
 
Bmi1  - B lymphoma Mo-MLV insertion region 1 homolog 
 
bp  - base pair 
 
Brg1  - Brahma-related gene 1 
 
BrdU  - 5-bromo-2′-deoxyuridine 
 
BSA  - bovine serum albumin 
 
Cbx2  - Chromobox homolog 2 
 
CNS  - central nervous system 
 
Ct  - threshold cycle 
 
CP  - cortical plate 
 
DAPI  - 4’,6-diamidino-2-phenylindole 
 
Dedaf  - Death effector domain-associated factor 
 
DMEM - Dulbecco’s modified eagle’s medium 
 
D-PBS  - Dulbecco's phosphate-buffered saline 
 
E2f  - E2 promoter binding factor 
 
EB  - embryoid body 
 
EDTA  - Ethylenediaminetetraacetic acid 
 
ES cells - embryonic stem cells 
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EYFP  - Enhanced yellow fluorescent protein 
 
Ezh1  - Enhancer of zeste homolog 1 
 
Ezh2  - Enhancer of zeste homolog 2 
 
FACS  - Flow cytometry analysis 
 
FBS  - fetal bovine serum 
 
Fbxl10 - F-box and leucine-rich repeat protein 10 
 
Fgf5  - Fibroblast growth factor 5 
 
Gfap  - Glial fibrillary acidic protein 
 
Gsc  - Goosecoid 
 
H&E  - hematoxylin-eosin 
 
HBS  - Hepes buffered saline 
 
Hprt  - Hypoxanthine phosphoribosyltransferase 1 
 
ICC  - Immunocytochemistry 
 
Ift57  - Intraflagellar transport 57 
 
IZ  - intermediate zone 
 
Jarid2  - Jumonji, AT rich interactive domain 2 
 
Jmj  - Jumonji 
 
Kdm2b - Lysine (K)-specific demethylase 2b 
   
LIF  - Leukemia inhibitory factor 
 
Lot1  - Lost on transformation 1 
 
Map2  - Microtubule-associated protein 2 
 
MapT  - Microtubule-associated protein tau 
 
MEF  - mouse embryonic fibroblast 
 
Mel18  - DNA-binding protein Mel-18 
 7 
 
MZ  - marginal zone 
 
N  - neuron 
 
Nanog  - Nanog homeobox 
 
ncPRC - non-canonical Polycomb repressive complex 
 
NeuN  - Neuronal nuclei 
 
NeuroD1 - Neurogenic differentiation 1 
 
NSC  - neural stem cell 
 
NPC  - neural progenitor cell 
 
NTD  - neural tube defect 
 
OC  - oligodendrocyte 
 
Oct4  - Octamer-binding protein 4 
 
Olig2  - Oligodendrocyte transcription factor 2 
 
padj  - adjusted p-value 
 
Pax6  - Paired box 6 
 
PBS  - phosphate buffered saline 
 
PcG  - polycomb group 
 
Pcgf  - Polycomb group ring finger 
 
PI  - propidium-iodide 
 
PFA  - paraformaldehyde 
 
Plagl1  - Pleiomorphic adenoma gene-like 1 
 
Pou5f1 - POU domain, class 5, transcription factor 1 
 
PRC  - Polycomb repressive complex 
 
qRT-PCR - quantitative real-time polymerase chain reaction 
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RA  - retinoic acid 
 
Rbfox3 - RNA binding protein fox-1 homolog 3 
 
Ring1a - Ring finger protein 1 
 
Ring1b - Ring finger protein 2 
 
RT  - room temperature 
 
Rybp  - Ring1 and Yy1 binding protein 
 
S  - subplate 
 
SD  - standard deviation 
 
SFEBq - Serum-free floating culture of EB-like aggregates with quick reaggregation 
 
Skp1  - S-phase kinase-associated protein 1 
 
Sox2  - SRY (sex determining region Y)-box 2 
 
Sox17  - SRY (sex determining region Y)-box 17 
 
SVZ  - subventricular zone 
 
TE  - Tris-EDTA 
 
Tubb3  - Tubulin, β 3 class III 
 
Tuj1  - Tubb3 antibody 
 
Usp7  - Ubiquitin specific peptidase 7 
 
VZ  - ventricular zone 
 
Yaf2  - Yy1 associated factor 2 
 
Yeaf1  - Yy1 and E4tf1-associated factor 1 
 
Yy1  - Yin and yang 1 protein 
 
Zac1  - Zinc finger protein regulating apoptosis and cell cycle arrest 
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1.   INTRODUCTION 
 
 
During vertebrate embryonic development every specialized cell type of the embryo develops 
from pluripotent embryonic stem cells (ES cells). ES cells have some unique abilities: they can 
indefinitely divide and self-renew, when each new cell remains a pluripotent stem cell or they 
can differentiate into a cell type with a specialized function, such as muscle or nerve cells.   
Remarkably they have the ability to contribute to the germline when introduced back to the 
early stage embryo. During embryonic development, specific regulators control the balance 
between differentiation and self-renewal. 
Polycomb group (PcG) proteins are epigenetic regulators of transcription with essential roles 
in maintaining ES identity and initiating cell lineage commitment throughout the process of 
differentiation. This study shows that the PcG protein Rybp (Ring1 and Yy1 binding protein, 
also known as Dedaf (Death effector domain-associated factor) and Yeaf1 (Yy1 and E4tf1-
associated factor 1)) has essential role in neural lineage commitment of pluripotent ES cells. 
 
1.1   Processes of neural differentiation 
 
The mammalian nervous system has an ectodermal origin. In the early phase of neural 
development embryonic ectoderm forms the neuroectoderm where the multipotent neural stem 
cells (NSCs) are developing (Bergquist, 1964). The NSCs can sequentially generate all neural 
cell types of the central nervous system (CNS) and the peripheral nervous system through 
asymmetric cell division, and they also have the capacity for self-renewal through symmetric 
cell division (Gage, 2000). The NSCs differentiate into two major types of neural progenitor 
cells (NPCs): neuronal progenitors and glial progenitors (also called radial glial stem cells), 
which can develop oligodendrocyte precursors (Figure 1). At this phase of neural development, 
the symmetric division of NSCs is dominant, which extends the NSC niche and provides the 
proper cell pool for the later processes.  
In the late phase of neural induction, terminal differentiation is prevalent. The differentiation 
of mature neuronal cell types begins when NPCs terminally exit from the cell-cycle (Lu et al., 
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2000). At the late neural phase, terminally differentiated neurons, astrocytes and 
oligodendrocytes form from their corresponding progenitors through asymmetric division in a 
defined order. Throughout neurogenesis the cells gradually lose their proliferation ability 
(Figure 1).  
 
 
Figure 1 – Schematic figure of the neural differentiation of the ES cells 
NSCs derive from pluripotent stem cells, then differentiate into neural progenitors and glial 
progenitors, which can develop oligodendrocyte precursors. These progenitors differentiate 
into mature neural cells in the late phase of neural development. Through differentiation the 
cells gradually lose their proliferation ability. RA: retinoic acid. 
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1.2   Markers of neural development 
 
The expression changes of transcription factors through neural development determine the 
emergence of different neural lineages. Expression of these factors is strictly governed both in 
space and time. Some factors play critical role in the early phase, other factors are important in 
the late phase of neural differentiation (Figure 2). Therefore, the expression changes of certain 
transcription factors indicate certain developmental stages and cell types through neural 
differentiation. 
Through differentiation processes key pluripotency factors (e.g. Nanog (Nanog homeobox), 
Oct4 (Octamer-binding protein 4; also known as Pou5f1 (POU domain, class 5, transcription 
factor 1)), which are responsible for maintaining the undifferentiated pluripotent phase, are 
gradually downregulated. Sox2 (SRY (sex determining region Y)-box 2) is an exceptional 
pluripotency marker gene whose expression marks early neural processes as well by facilitating 
differentiation of stem cells to NSCs and NPCs, and maintains their self-renewal capacity 
(Graham et al., 2003; Thomson et al., 2011). 
At the onset of neural differentiation Pax6 (Paired box 6) is upregulated, which induces the 
NSC formation (Gajović et al., 1997). Level of Pax6 is also elevated in the NPCs, but in 
maturing neural cells its level is decreased. Pax6 has an intense effect on controlling cell-cycle 
exit, which is a highly controlled process during neural differentiation (Farhy et al., 2013). 
Nestin is another marker of early neural processes and it is important for the development of 
NSCs and NPCs (Lendahl et al., 1990). This protein is important for the survival, the self-
renewal and the proliferation of NPCs, and the radial growth of the axons during embryonic 
development. NeuroD1 (Neurogenic differentiation 1) is also important for the early neural 
phase since it plays role in the transition from the NPC state to the maturing neural state (Boutin 
et al., 2010). 
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Figure 2 – Expression changes of pluripotency markers and neural markers through neural 
differentiation 
Pluripotent factors are marked with green. Early and late neural differentiation markers are 
shown with pink and red colors, respectively. 
 
Through the transition from early to late neural stage the developing NPCs start to express β-
tubulin (also known as Tubb3 (Tubulin, beta 3 class III)). β-tubulin is important for the late 
phase of neural differentiation as it provides microtubule stability in the developing 
neurofilaments (Black et al., 1984) and its level remains high in mature neuronal cell types. β-
tubulin is expressed exclusively in neurons (Fanarraga et al., 1999). Another mature neuronal 
marker is NeuN (Neuronal nuclei, also known as Rbfox3 (RNA binding protein fox-1 homolog 
3)), which shows high expression in postmitotic neurons (Mullen et al., 1992). One of the 
important factors for the formation of oligodendrocytes is Olig2 (Oligodendrocyte transcription 
factor 2) (Mizuguchi et al., 2001; Takebayashi et al., 2002; Zhou et al., 2000), while in maturing 
astrocytes the Gfap (Glial fibrillary acidic protein) shows elevated expression (Bignami et al., 
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1972; Eng et al., 1971), although it is also expressed in the radial glias. 
Besides cell lineage markers some other genes are also critical for proper neural differentiation, 
such as Plagl1 (Pleiomorphic adenoma gene-like 1; also known as Zac1 (Zinc finger protein 
regulating apoptosis and cell-cycle arrest) and Lot1 (Lost on transformation 1)). It was first 
described as a tumor suppressor (Abdollahi et al., 1997) and an important regulator of apoptosis 
and cell-cycle arrest since it has antiproliferative activity (Spengler et al., 1997). Plagl1 plays 
crucial role in neural development (Valente and Auladell, 2001) since plagl1 null mutant mice 
show defects in cortex development (e.g., reduced size of cerebellum, reduced number of 
mature neurons) (Chung et al., 2011), defects of neural tube closure and heart development as 
well (Yuasa et al., 2010). Plagl1 expressed in the neuroectoderm, in the progenitor cells of the 
telencephalic and cerebellar ventricular zones (VZs), the external granular cell layer, the retina 
and the developing heart (Valente et al., 2005).  
 
 
1.3   In vitro neural differentiation methods 
 
In vitro neural differentiation recapitulates the steps of in vivo neural development that occurs 
in the embryo. Therefore, the in vitro neural differentiation methods are excellent model 
systems of the in vivo development and allow the investigation of the spatiotemporal 
differentiation events at various developmental stages in the absence of environmental cues. 
Furthermore, all major neural cell types of the CNS can be generated and cultured under specific 
circumstances. These differentiated neural cells exhibit morphological and molecular properties 
of cultured primary neurons, and exhibit physiological functionality when transplanted into 
animals (Hemmer et al., 2014; Wernig et al., 2004). 
Several in vitro differentiation methods have been developed to generate neural cells from ES 
cells (Figure 3) by co-culturing ES cells with stromal cells, culturing ES cells in monolayer, 
formation of embryoid bodies (EBs) and the formation of “cerebral organoids”. 
Neural differentiation can be facilitated in vitro by co-culturing ES cells on the surface of 
stromal cells in the absence of serum (Kawasaki et al., 2000). The stromal cells are special 
connective tissue cells, which produce inducing and inhibitory factors in co-culture system that 
promotes neural differentiation. 
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ES cells in monolayer are also able to generate neural lineages (Tropepe et al., 2001). It has 
been described that ES cells cultured in serum-free medium at low cell density differentiate into 
“NSC-like” cell population. These “NSC-like” cultures can be further cultured on matrigel 
substrate in order to generate neurons, astrocytes, and oligodendrocytes. 
An other method of in vitro neural differentiation is mediated by so called embryoid bodies 
(EBs). Formation of EBs can be generated in suspension cultures, in the presence of serum, 
when cells form three-dimensional cell aggregates. These aggregates mimic many hallmarks of 
early embryonic development such as forming all major germ layers: ecto-, endo- and 
mesoderm. Neuroectodermal formation can be facilitated by adding retinoic acid (RA) to the 
culture medium and the dosage of RA influences the properties of the developing neural cells 
(Bain et al., 1995). Differentiation of ES cells into neural lineages without RA treatment is also 
a routine procedure when the EBs are sequentially cultured in medium containing serum 
followed by serum-free medium (Okabe et al., 1996). After dissociation of EBs, the plated cells 
express neural markers and show typical neural physiological properties. 
A recently developed method is the formation of SFEBq culture (Serum-free floating culture 
of EB-like aggregates with quick reaggregation), also known as cerebral organoids (Eiraku et 
al., 2008; Lancaster et al., 2013; Nasu et al., 2012). In these “organoids” the cells self-organize 
into structures which mimic many aspects of in vivo cortical development, including formation 
of cell layers which partially show the characteristics of discrete brain regions. 
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Figure 3 – Commonly used in vitro neural differentiation methods 
Generation of neural lineages from ES cells in vitro is feasible by using differentiation of ES 
cells in co-culture with stromal cells, culturing ES cells in monolayer, via the formation of EBs 
and creating cerebral organoids. ES cells: embryonic stem cells, EB: embryoid body, RA: 
retinoic acid. 
 
 
1.4   Rybp, a critical regulator of neural development 
 
Rybp is an evolutionarily conserved transcription regulator. In mouse the rybp gene is located 
on the 6th chromosome, the size of the gene is 58 794 bp and its protein product is 228 aa long. 
The human RYBP is 99% homologous to the mouse Rybp protein and the rybp gene is located 
on the 3rd chromosome. The RYBP protein was isolated first as an interacting partner of the 
PcG protein Ring1a (also known as Ring1; Ring finger protein 1), Yy1 (Yin and yang 1 protein), 
Ring1b (also known as Ring2/Rnf2; Ring finger protein 2), and Cbx2 (Chromobox homolog 2; 
also known as M33) (García et al., 1999). Ring1a and Ring1b bind to the C-terminal region of 
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Rybp, while Yy1 and Cbx2 interact with different domains of Rybp (García et al., 1999). The 
Rybp protein is partially homologous to Yaf2 (Yy1 associated factor 2), an other Yy1 binding 
protein, and together they constitute a cofactor family (Sawa et al., 2002). 
Rybp, together with Ring1a and Ring1b, are members of non-canonical Polycomb repressive 
complex 1 (ncPRC1), also known as PRC1.1 (Chen and Dent, 2014; Farcas et al., 2012; He et 
al., 2013; Oliviero et al., 2015; Schwartz and Pirrotta, 2013; Turner and Bracken, 2013). PRC 
complexes have important role in cell lineage specification by maintaining ES cell pluripotency 
through repression of developmental regulators (Boyer et al., 2006; Simon and Kingston, 2013). 
The PRC1.1 complex encompassing Bcor (Bcl6 (B-cell lymphoma 6 protein) corepressor) as 
well, which plays important role in the differentiation of ES cells into ectoderm and mesoderm 
(Wamstad et al., 2008). In addition, Rybp interacts with chromatin modifiers (Brg1 (Brahma-
related gene 1)) (He et al., 2010) and pro-apoptotic factors (Pro-caspase 8, Pro-caspase 10, 
Ift57 (Intraflagellar transport 57; also known as Hippi),) (Stanton et al., 2007; Zheng et al., 
2001). Several studies described downregulation of Rybp in tumors (Chen et al., 2009; Li et al., 
2013; Taylor et al., 2010) and its forced expression helps to induce apoptosis and increased 
chemosensitivity of the tumor cells (Novak and Phillips, 2008; Voruganti et al., 2015; Wang et 
al., 2014; Zeng et al., 2015; Zhao et al., 2016). 
In embryos Rybp is expressed in the developing CNS, especially in spinal cord, the 
pseudostratified neuroepithelial cells of the neural plate, some layers of the developing cortex 
including marginal zone (MZ), cortical plate (CP) and subventricular zone (SVZ), and the 
olfactory epithelium. Postnatally Rybp is expressed in outer cortical neurons of the forebrain 
and midbrain, and in the dentate gyrus of hippocampus (García et al., 1999; Pirity et al., 2005). 
Our laboratory previously showed that in a portion (15-25%) of the rybp+/- mice there were 
striking neural tube defects (NTDs). These mutant mice exhibited exencephaly, lack of 
cerebellum and failure of the closure of neural tube. (Pirity et al., 2005). One of the most striking 
effects was the disorganization of the neocortex in the rybp heterozygous mutant mice (Figure 
4). The most affected parts in the cortex of rybp+/- mice were the CP, the intermediate zone (IZ) 
and SVZ, where important steps of the corticogenesis take place, underlying the possible role 
of Rybp in this process. 
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Figure 4 – Sections of the cortex of wild type and rybp heterozygous mice 
The cortex of the rybp heterozygous mice (rybp+/-) is disorganized compared to the cortex of 
the wild type mice. In the rybp+/- cortex the CP is thicker and the IZ is absent. S: subplate, MZ: 
marginal zone, CP: cortical plate, IZ: intermediate zone, VZ: ventrical zone. 
 
During my work I investigated underlying molecular events of the previously described CNS 
phenotype of the rybp heterozygous mice. We hypothesized that Rybp regulates genes, which 
are important for neural lineage commitment and in absence of Rybp the cells cannot undergo 
differentiation or has impaired differentiation ability. Since the early embryonic lethality of the 
rybp null mutant mice obscures the genetic analysis of neural lineage commitment in vivo, we 
utilized an in vitro ES cell based system to investigate the role of Rybp during neural 
differentiation. 
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2.   AIMS OF THE STUDY 
 
 
The main goal of this thesis was to characterize the role of Rybp in neural lineage commitment. 
 
The detailed aims of this study were: 
- to examine whether the rybp null mutant mouse ES cells are capable to differentiate into all 
major neural lineages (neuron, oligodendrocyte, astrocyte). 
- to characterize the properties of the progenitor cells derived from rybp null mutant mouse ES 
cells, especially with regard to their ability to balance self-renewal and differentiation during 
neural development. 
- to determine which cell types have impaired differentiation capability as a result of Rybp 
absence. 
- to find candidate downstream target genes of Rybp that have changed their expression 
depending on the presence or absence of Rybp during neural differentiation. 
 
By aiming these, we hoped to gain more detailed information about the process of neural 
differentiation in vitro and to broaden our current understanding of congenital and neurological 
diseases. Besides this, in vitro generation of neurons from ES cells raises the prospect for 
potential future applications such as pharmacological testing systems to studying the 
pathogenesis of human diseases. 
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3.   MATERIALS AND METHODS 
 
 
3.1   Chemicals 
 
All chemicals were purchased from Sigma-Aldrich (St Louis, MO, USA), and culture media 
were purchased from Invitrogen Life Technologies (Carlsbad, CA, USA), unless stated 
otherwise. 
 
 
3.2   Cell lines and culture condition 
 
Mouse (129SV/Ola) R1 ES cells (Nagy et al., 1993) (hereafter mentioned as rybp+/+ or wild 
type) and D11 ES cells (Pirity et al., 2005) (hereafter mentioned as rybp-/- or null mutant) 
(Figure 5) were thawed on mitomycin C inactivated mouse embryonic fibroblast (MEF) layer 
and cultured on gelatin coated tissue culture plates as described (Magin et al., 1992). 
The cells were maintained in ES medium: Dulbecco’s modified eagle’s medium (DMEM (1x) 
+ GlutaMAX™-I Dulbecco`s Modified Eagle Medium, Gibco, Cat. No 31966-021) contained 
15% (vol/vol) fetal bovine serum (Gemini Stasis Stem Cell Qualified FBS, West Sacramento, 
CA, USA, Cat. No 100-125), 0.1mM non essential amino acids (MEM Non Essential Amino 
Acids (100x), PAA, Cat. No M11-003), 0.1mM β-mercaptoethanol (2-Mercaptoethanol, Gibco, 
Cat. No 31350-010), 1% glutamine (L-Glutamine (200mM) Gibco, Cat. No 25030-081), 1% 
sodium pyruvate (Sodium Pyruvate (100mM), Gibco, Cat. No 11360-070), 50 U/ml 
penicillin/streptomycin (Penicillin/Streptomycin (100x), PAA, Cat. No P11-010), and 
1000 U/ml Leukemia inhibitory factor (LIF, ESGRO, Chemicon/Millipore, Billerica, MA, 
USA). The cells were passaged prior to reaching 70% confluence (approximately every 1–2 
days). ES cells were cultured on gelatin coated dishes for at least two passages prior to 
differentiation to deplete potentially present MEF cells from the ES cell culture. Cells were 
cultured in a humidified atmosphere containing 5% CO2 at 37°C. ES medium was changed 
daily. 
COS7 cells were maintained in DMEM (DMEM with 4.5 g/l glucose & L-glutamine, Lonza, 
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Cat. No BE12-604F) contained 10% (vol/vol) FBS (Heat Inactivated FBS, Gibco, Cat. No 
10500), 0.1mM non essential amino acids (MEM Non Essential Amino Acids (100x), PAA, 
Cat. No M11-003), 1% sodium pyruvate (Sodium Pyruvate (100mM), Gibco, Cat. No 11360-
070) and 50 U/ml penicillin/streptomycin (Penicillin/Streptomycin (100x), PAA, Cat. No P11-
010)). The cells were passaged prior to reaching 95% confluence (approximately every 3–4 
days). Medium was changed every second day. Cells were cultured in a humidified atmosphere 
containing 5% CO2 at 37°C. 
 
 
Figure 5 –ES cell lines used in this study 
In wild type cells (rybp+/+), the rybp genomic locus contains 5 exons. In the rybp homozygous 
null cells (rybp-/-) the EYFP (Enhanced yellow fluorescent protein) following a floxed  neomycin 
cassette is replacing exons 3, 4 and 5 creating a functional null mutant. 
 
 
3.3   In vitro neural differentiation of mouse embryonic stem cells 
 
ES cells were induced to differentiate into neuronal lineages as Bibel et al described, with some 
modifications (Bibel et al., 2004) (Figure 6). In brief, mouse ES cells were harvested as single 
cell suspension using 0.05% (wt/vol) trypsin (Trypsin-EDTA (1x) 0,05% / 0,02% in D-PBS, 
PAA, Cat. No L15-004), then seeded at a density of 4.5x105 cells/ml in ES medium without 
LIF into 100 mm2 bacteriological dishes where cell attachment was prevented. ES cells were 
allowed to aggregate in suspension and formed embryoid bodies (EBs) for 8 days. Medium was 
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changed on every second day during differentiation unless stated otherwise. On the 4th day of 
EB formation 5 µM all-trans RA (Retinoic acid, Sigma, Cat. No R2625-100MG) was added to 
the medium and EBs were cultured for a further 4 days in the presence of RA. Thereafter, 8-
day-old EBs were dissociated using trypsin and plated onto poly-L-ornithine (Poly-L-Ornithine 
0.01%, Sigma, Cat. No P4957) and laminin (Laminin from Engelbreth-Holm-Swarm murine 
sarcoma basement membrane, Sigma, Cat. No L2020-1MG) coated dishes at a density of 3x105 
cells/cm2 in DMEM/F-12 medium containing 3 mg/ml of D-(+)-glucose, 3 mg/ml AlbuMax I, 
50 U/ml penicillin/streptomycin, 1% (vol/vol) N-2 supplement (N-2 Supplement (100x), 
Gibco, Cat. No 17502-048), and 10 ng/ml recombinant human bFGF (Fibroblast Growth Factor 
Basic, human, Sigma, Cat. No F0291-25UG). The medium was changed 24 hours later. Two 
days after cells were plated, the medium was changed to DMEM/F12:	Neuronal Base Medium 
(Neuronal Base Medium For Neuronal Cells, PAA, Cat. No U15- 023) (1:1)) containing 1 mM 
GlutaMax, 3 mg/ml AlbuMax I, 50 U/ml penicillin/streptomycin, 0.5% (vol/vol) N-2 
Supplement, and 1% (vol/vol) B-27 supplement (B-27 Supplement (50x), Gibco, Cat. No 
17504-044) and the cells were cultured for a further 4 days. The medium was changed 2 days 
later. The cells were harvested for further analyses at different time points of neural 
differentiation: days 0, 3, 7, 10 and 14 (labeled as d0, d3, d7, d10, d14). On d10 and d14 the 
differentiated cells were also stained with cresyl violet in order to visualize the cell colonies 
and morphology of the cells. The images of the ES cell cultures, EBs and stained neural culture 
were obtained using Olympus cellR microscope (Olympus Corporation, Japan). 
 
 
Figure 6 - In vitro neural differentiation 
Schematic illustration of in vitro neural differentiation as described by Bibel et al.  
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3.4   Histological evaluation of embryoid bodies 
 
We assessed tissue organization and cellular morphology by histological evaluation of 
sectioned EBs. EB sectioning was performed by Hisztopatológia Kft. (Pécs, Hungary). The 
harvested EBs (d3, d7) fixed with 4% paraformaldehyde (PFA) (Paraform-aldehyde, Sigma, 
Cat. No P6148), then stored in PBS. The PFA fixed EBs are first pelleted and embedded with 
HistoGel (Thermo Scientific, Cat. No HG-4000-012) in order to concentrate the EBs for 
subsequent embedding with paraffin. Liquefied HistoGel was added to the pellet, it was 
resuspended carefully in the HistoGel and let it to solidify by cooling at room temperature. The 
solidified HistoGel was placed in a tissue processor cassette, dehydrated with acetone, cleared 
it in xylene, infiltrated it with molten paraffin and let it to solidify. After the block was solidified 
it was sectioned with a Thermo Scientific HM325 Rotary Microtome. All cell blocks were cut 
on the microtome at 3-4 µm. The sections mounted on microscope slides and stained with 
hematoxylin-eosin (H&E) in order to enhance contrast between the tissues and cells. The 
sections were scanned with Panoramic DESK system. Using these techniques, various tissues 
can be commonly recognized such as neural rosette-like structures.  
 
 
3.5   Quantitative real-time PCR (qRT-PCR) 
 
For quantitation of mRNA levels during the in vitro differentiation quantitative real-time PCR 
(qRT-PCR) assays were performed. Total RNA was extracted from the harvested cells using 
Qiagen RNeasy Plus Mini Kit (Qiagen, Cat. No 74134 Hilden, Germany) according to the 
manufacturer’s instructions. cDNA synthesis was achieved with the isolated RNA using 
Applied Biosystems High capacity cDNA Reverse Transcription Kit (Invitrogen Life 
Technologies, Cat. No 4368814 Carlsbad, CA, USA) according to the manufacturer’s 
instructions. 
qRT-PCR was performed in SYBR Green master mix (SYBR® Select Master Mix for CFX, 
Applied Biosystems, Cat. No 4472942) using Bioer LineGeneK Real-time PCR System (Bioer, 
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China). Relative gene expression changes were quantified using the ΔΔCt method. The 
threshold cycle (Ct) values for each gene were normalized to expression level of Hprt 
(Hypoxanthine phosphoribosyltransferase 1), as internal control. To calculate fold change, the 
values compared to undifferentiated samples (d0, rybp+/+). The primers used in this study were 
listed in Table 1. Unigene and Mouse Genome Informatics (MGI) ID numbers of examined 
markers are listed at Appendix B, Table S1. 
 
Gene name Forward primer sequence Reverse primer sequence 
Ezh1 5’-AATATGGGAGCAAAGGCTCTGTATGTG-3’ 5’-CACGAAGTTTCTTCCACTCTTCATTGAG-3’ 
Ezh2 5’-TTACTGCTGGCACCGTCTGATGTG-3’ 5’-TGTCTGCTTCATCCTGAGAAATAATCTCC-3’ 
Fgf5 5’-CAAAGTCAATGGCTCCCACGAAG-3’ 5’-CTACAATCCCCTGAGACACAGCAAATA-3’ 
Gfap 5’-AGATGAAACCAACCTGAGGC-3’ 5’-CCTCCAGCGATTCAACCTTT-3’ 
Gsc 5’-TCCAGGAGACGAAGTACCCAGACGT-3’ 5’-CTCGGCGGTTCTTAAACCAGACCT-3’ 
Hprt 5’-AGTCCCAGCGTCGTGATTAG-3’ 5’-GCAAGTCTTTCAGTCCTGTCC-3’ 
Jmj 5’-AGGCGGTAAATGGGCTTCTTGGTA-3’ 5’-AGCCTGGGCCTTTTCCTCGAC-3’ 
Map2 5’-AAAGAGAACGGGATCAACGG-3’ 5’-TTGTGTTGGGCTTCCTTCTC-3’ 
Nanog 5’-CAAGGGTCTGCTACTGAGATGCTCTG-3’ 5’-TTTTGTTTGGGACTGGTAGAAGAATCAG-3’ 
Nestin 5’-AGTGCCCAGTTCTACTGGTGTCC-3’ 5’-CCTCTAAAATAGAGTGGTGAGGGTTGA-3’ 
NeuN 5’-AATACATTTCGAGCTGCACCA-3’ 5’-AACAAGCGTTTGCTCCAGT-3’ 
NeuroD1 5’-CGAGTCATGAGTGCCCAGCTTA-3’ 5’-CCGGGAATAGTGAAACTGACGTG-3’ 
Oct4 5’-AGCCGACAACAATGAGAACC-3’ 5’-TCTCCAGACTCCACCTCACA-3’ 
Olig2 5’-CGCAGCGAGCACCTCAAATCTAA-3’ 5’-CCCAGGGATGATCTAAGCTCTCGAA-3’ 
Pax6 5’-CTTGGGAAATCCGAGACAGA-3’ 5’-CTAGCCAGGTTGCGAAGAAC-3’ 
Plagl1 5’-ATGGCTCCATTCCGCTGTC-3’ 5’-CTCAGCCTTCGAGCACTTGAA-3’ 
Ring1a 5’-TGCCTGCATAGGTTCTGCTC-3’ 5’-GACCGCTTGGATACCAGCTT-3’ 
Ring1b 5’-ACAATCAGCAGGCTCTCAGC-3’ 5’-CAGTGGGAGCTGTCACCATT-3’ 
Rybp 5’-TTAGGAACAGCGCCGAAG-3’ 5’-GCCACCAGCTGAGAATTGAT-3’ 
Sox2 5’-GCAGTACAACTCCATGACCA-3’ 5’-TAGGACATGCTGTAGGTGGG-3’ 
Sox17 5’-GCCAAAGACGAACGCAAGCG-3’ 5’-TTCTCTGCCAAGGTCAACGCCT-3’ 
Tau 5’-ATGTCAGGTCGAAGATTGGC-3’ 5’-ATTATCTGCACCTTGCCACC-3’ 
Tubb3 5’-TGAGGCCTCCTCTCACAAGT-3’ 5’-GGCCTGAATAGGTGTCCAAA-3’ 
Yy1 5’-TGCCCTCATAAAGGCTGCAC-3’ 5’-CTCTCAACGAACGCTTTGCC-3’ 
 
Table 1 – Primers used in qRT-PCR reactions 
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3.6   Immunocytochemistry (ICC) analysis 
 
For immunofluorescence staining of the neural cell culture, the cells were plated onto 
coverslips, differentiated into neuronal lineages as described above and fixed with 4% PFA for 
20 min at room temperature (RT). After permeabilization in 0.2% Triton X-100 (Triton® X-
100, Sigma, Cat. No T8787-250ML) in PBS (D-PBS (1X) Dulbecco`s Phosphate Buffered 
Saline, Gibco, Cat. No 14190-094) for 20 min at RT, cells were blocked in 5% bovine serum 
albumin (BSA)	(Albumine from bovine serum, Sigma, Cat. No A7906) in PBS for 1h at RT. 
Then sequentially incubated with the following primary antibody in 5% BSA overnight at 4°C: 
2H3 (2H3, Hybridoma Bank, Iowa, USA, 1:1000), Gfap (Monoclonal Anti-Glial Fibrillary 
Acidic Protein Clone G-A-5, Sigma, Cat. No G3893, 1:400), Map2 (Anti-MAP2 antibody, 
Abcam, Cat. No ab32454, 1:1000), Nestin (Rat-401, Hybridoma Bank, Iowa, USA, 1:100), 
Pax6 (Pax6, Hybridoma Bank, Iowa, USA, 1:100), RC2 (RC2, Hybridoma Bank, Iowa, USA, 
1:100), Tau (Tau (H-150), Santa Cruz Biotechnology, Cat. No sc-5587, 1:100), Tuj1 (Neuronal 
Class III β-Tubulin Polyclonal Antibody; Covance, Cat. No PRB-435P, 1:2500), and 
Zac1/Plagl1 (Zac1 (M-300), Santa Cruz Biotechnology, Cat. No sc-22812, 1:1000). The cells 
were washed 5 times with PBS and incubated with fluorescent-labeled secondary antibody 
(Alexa Fluor 488 Goat-Anti-Mouse, Invitrogen, Cat. No A-10667; Alexa Fluor 647 Donkey-
Anti-Mouse, Invitrogen, Cat. No A-31571; Alexa Fluor 647 Goat-Anti-Rabbit, Invitrogen, Cat. 
No A-21244) for 1h at RT. Then the cells were washed 3 times with PBS. The cells were rinsed 
in 4’,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Cat. No H-1200) for 20 min, 
washed 2 times with PBS and mounted in 50% glycerol. The images were obtained using 
Olympus LSM confocal microscope (Olympus Corporation, Japan). 
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3.7   Analysis of immunostaining 
 
Semi-quantification of 2H3, Gfap, Map2, Nestin, Pax6, RC2, Tau, Tuj1 and Plagl1 levels and 
the percentage of immunopositive cells was evaluated with ImageJ software (Rasband, W.S., 
National Institutes of Health, Bethesda, MD, USA). 
 
 
3.8   Global gene expression analysis by next-generation sequencing 
 
ES cells from a 6 cm culture dish were harvested by resuspension in 500mL TRIzol (TRIzol 
Reagent, Invitrogen, Cat. No 15596026), and total RNA was extracted with the TRIzol method 
according to the manufacturer’s instructions. RNA was quality controlled by nanodrop and 
bioanalyzer. The extracted RNA was converted to cDNA and Illumina-compatible sequencing 
libraries using NuGEN Ovation and Encore NGS kits. Barcoded libraries were pooled and 
sequenced on an Illumina Genome Analyzer GAIIx in the single read mode with 80 nt read 
length. Reads were mapped to the mouse genome using TopHat (Trapnell et al., 2009). 
Differentially expressed genes between rybp+/+ and rybp-/- ES cells were identified with DESeq 
and filtered for having a fold change > 1.5 or < -1.5 and false discovery rate < 0.05. In the case 
of increasing gene expression, the fold change value was calculated by the expression ratio of 
the rybp null mutant and the wild type samples; however, when the gene expression showed a 
decreasing tendency, the negative reciprocal of this quotient was used for the fold change 
calculation. 
 
 
3.9   Flow cytometry analysis (FACS) 
 
Cultured cells and EBs were incubated with 10 µM BrdU (5-Bromo-2′-deoxyuridine, Sigma, 
Cat. No B9285-250MG) for 1h, then trypsinized into single cells and washed with PBS. Cells 
were fixed in 70% ice cold ethanol for 20 min, denatured with 2M HCl for 20 min and 
neutralized with 0.1 M sodium borate (Na2B4O7, Molar Chemicals, Cat. No 07470-101-190, 
pH 8.5). Following washing with washing buffer (0.5% BSA diluted in PBS), cells were stained 
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with the primary monoclonal antibody anti-BrdU (BD Pharmingen, Cat. No 555627 1:100 
diluted in dilution buffer contains 0.5% BSA and 0.5% Tween20 (Sigma Tween® 20, Cat. No 
P5927-500ML) for 30 min at RT. Cells were washed with washing buffer, then incubated with 
Alexa Fluor® 647–labeled secondary antibody (Invitrogen, Cat. No A-31571, Donkey-Anti-
Mouse, 1:1000) for 30 min at RT in dark. The cells were washed and resuspended in propidium-
iodide (PI) (Propidium-iodide, Sigma, Cat. No P4170) (10 µg/ml in PBS) then incubated for 30 
min at RT in dark. Flow cytometry was performed using a Becton-Dickson FACS Calibur flow 
cytometer (Palo Alto, Temecula, CA, USA). FACS analysis was performed on different time 
points of neural differentiation d0, d3, d7, d10 and d14). 
 
 
3.10   Luciferase reporter assay 
 
COS7 cells were cotransfected with the following vectors: pGL3.Plagl1-Luc (a kind gift of 
Michael P. Czubryt), pcDNA3.1-HA:Rybp. We transfected these vectors in various 
concentrations (pGL3.Plagl1-Luc: 5 µg, pcDNA3.1-HA:Rybp: 1 µg, 5 µg, 25 µg) using CaPO4 
transfection (Kingston et al., 2003; Wigler et al., 1979). CaPO4 transfection were performed as 
follows: 8 hours before transfection the cell culture medium was changed, the vectors were 
diluted in TE (Tris-EDTA (Trizma® base, Sigma, Cat. No T1503)) buffer, then we added 2.5 
M CaCl2 and 2x HBS (Hepes buffered saline (Hepes, Sigma, Cat. No H3375)) dropwise to the 
solution while we bubbled the mix providing oxygenation, finally we added this solution to the 
medium. 16 hours after transfection cell culture medium was changed. 48 hours after 
transfection the cells were washed with PBS and lysed with 1x Passive lysis buffer provided by 
reporter assay kit (Dual Luciferase Reporter Assay System, Promega, Cat. No E1500). 20 µg 
of lysate from each point was mixed with 100 µl Luciferase Assay Reagent II (provided by the 
kit) and the luciferase activity recorded immediately, according to the manufacturer’s 
instructions. The luciferase activity was recorded with Perkin Elmer TopCount NXT 
Luminometer. All activities were measured in triplicate. 
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3.11   Statistical analysis 
 
All experiments were repeated three times. Experiments were evaluated with SPSS/PC+ 
version 17 program (SPSS, Chicago, IL) by using T-test type 3. The global gene expression 
analysis was evaluated by using Benjamini-Hochberg method (padj: adjusted p-value). 
Throughout the thesis, all data are expressed as mean ± standard deviation (SD). Values of p ˂ 
0.05 were accepted as significant (* p < 0.05; ** p < 0.01; *** p < 0.001). 
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4.   RESULTS 
 
 
4.1   Morphology of rybp-/- neural derivatives indicated impairment in neural 
differentiation 
 
In order to model the in vivo neural phenotype of the rybp+/- mice we took advantage of the ES 
cell based in vitro neural differentiation system. Thus, we adopted the protocol by Bibel et al. 
in order to differentiate rybp+/+ and rybp-/- ES cells towards neural cell lineages (Bibel et al., 
2004) (described in Materials and methods). In brief, suspension cultures were initiated using 
4.5 x 105 cells/ml seeding density and were kept in suspension for 8 days to form EBs. RA was 
added to the suspension cultures on the 4th day (d4) and EBs were kept in RA supplemented 
medium until trypsinization on the 8th day (d8), then seeded onto poly-L-ornithine/laminin 
coated surfaces in 3 x 105 cells/cm2 seeding density and differentiated further for six days. 
Samples for analysis were taken at d0, d3, d7, d10, d14 and processed as required. 
 
 
Figure 7 - Morphological changes of rybp+/+ and rybp-/- cells through in vitro neural 
differentiation 
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The rybp-/- ES cells displayed the same morphology in culture as the wild type (d0) and were 
able to form EBs (d3, d7). After plating (d10, d14) the rybp-/- cells grew less organized neural 
network than the wild type. Objectives: 4x (d3, d7), 10x (d0, d10, d14). Scale bars: 200 µm 
(d0), 500 µm (d3). 
 
Rybp-/- ES cells displayed similar morphology in culture as the wild type cells (Figure 7 d0). 
EBs could be derived from both cell lines. As expected, EBs started to cavitate around day 2-3 
(Figure 7 d3, dark core of EBs) and from day 4 endoderm and primitive ectoderm started to 
form as well. These suggested that rybp-/- cells were not compromised in their ability to 
proliferate and form EBs and they exhibited similar gross morphology (d3, d7) all over. 
However, H&E stained sections of EBs pinpointed morphological differences between the two 
cell lines. On d3 EBs showed homogeneous morphology in both cell lines, and by d7 “neural 
rosette-like” structures formed, which constituted of neuroepithelial cells. The formation of 
“neural rosette-like” structures was accelerated in the rybp-/- EBs in comparison to the wild 
type. (Figure 8, black arrows). 
 
 
Figure 8 – H&E stained sections of rybp+/+ and rybp-/- EBs showed differences in germ layer 
formation 
EBs at d3 showed homogeneous structure in both cell lines, while at d7 neural rosette-like 
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structures (black arrows) formed inside of EBs in both cell lines. Neural rosette-like structure 
formation was accelerated in rybp null mutant compared to wild type. Magnification: 20x. 
Scale bar: 100 µm. 
 
After dissociation of EBs and plating cells onto poly-L-ornithine and laminin coated surfaces 
(d8), the wild type cells exhibited typical neuronal morphology, the cells grew axon-like 
outgrowth, connected to each other and organized in a complex network consisting of 
heterogenous cell population. On the contrary, rybp-/- derivatives grew less neurite processes 
and their organization into complex network was less extended in comparison to the wild type 
(Figure 7 d10, d14). This difference was also observed at d10, but it was more prominent at 
d14. This phenotype was independent from the initial cell density (Figure 7 d10, d14; data not 
shown). The gross morphology of the cells suggested that neuronal differentiation was severely 
affected by the absence of Rybp. 
 
 
4.2   Attenuation of pluripotency markers was complete throughout in vitro neural 
differentiation 
 
To uncover underlying mRNA expression changes during in vitro neural differentiation we 
evaluated gene expression levels of rybp+/+ and rybp-/- cultures by qRT-PCR (Figure 9). 
First we analyzed the expression of pluripotency markers in both cell lines at d0, d3, d7, d10 
and d14. In undifferentiated stem cells, pluripotency factors work together with epigenetic 
regulators to maintain the pluripotent state and to suppress differentiation related genes. 
Incomplete silencing of the pluripotency genes during differentiation may cause impaired 
neural differentiation, therefore we had checked whether silencing of key pluripotency genes 
were proper in the absence of Rybp (Figure 9A). The analysis revealed that the expression of 
the examined pluripotency markers (Oct4, Nanog are shown on Figure 9BC) were progressively 
downregulated in both cell lines by differentiation and there were no significant changes in the 
kinetics of pluripotency gene expression between the rybp+/+ and rybp-/- cells. These results 
suggested that the silencing of pluripotency genes was properly executed in both cell lines. 
The relative expression level of pluripotency marker Sox2 was similar in both cell lines, with 
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the exception on d14 when the level of Sox2 is diminished in the rybp null mutant whilst it 
remained high in the wild type (Figure 9D). Although Sox2 together with Oct4 and Nanog 
maintains pluripotency in stem cells, it is also important in the induction of neuroectoderm and 
maintains self-renewal of NPCs. This suggested that the differentiation ability of rybp null stem 
cells to NPCs or maintaining the characteristics of NPCs might be compromised. These results 
suggested that the silencing of key pluripotency genes exhibited similar kinetics with the 
exception of Sox2, which in the rybp null mutant drastically declined by d14. 
 
 
Figure 9 - In the lack of Rybp there was no change in silencing of key pluripotency markers 
(Oct4, Nanog, Sox2) during in vitro neural differentiation 
Relative gene expression analysis of Rybp (A), Oct4 (B), Nanog (C) and Sox2 (D) by qRT-PCR 
showed that silencing of pluripotent factors was properly executed in both cell lines. The 
expression of the indicated markers was normalized to Hprt expression, which used as an 
internal control. Means are standard deviation ± SD. Values of p ˂ 0.05 were accepted as 
significant (* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
 
4.3   Lack of Rybp had minor influence on the expression of key PRC members 
 
Since PRCs play important role in maintaining pluripotency (Boyer et al., 2006; Simon and 
Kingston, 2013) and absence of Rybp may also effect PRC function, we wanted to check if the 
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level of key PRC components has changed in the absence of Rybp during in vitro neural 
differentiation. We checked the relative expression changes of the PRC1 (Ring1a, Ring1b) and 
PRC2 (Ezh1 (Enhancer of zeste homolog 1), Ezh2 (Enhancer of zeste homolog 2)) members, 
using qRT-PCR analysis. We also checked the expression changes of Yy1, a known interactor 
of Rybp, and Jmj (Jumonji, also known as Jarid2 (Jumonji, AT rich interactive domain 2)), a 
known modulator of PRC2. 
In our experiments during neural differentiation Ring1a and Ring1b mRNAs showed elevated 
expression when neural differentiation occurs with a peak at d10. In the rybp null mutant cells 
the relative gene expression level of Ring1a was half as much as in the wild type (Figure 10A), 
however, the expression of Ring1b and Yy1 was unaltered (Figure 10BC). 
At undifferentiated state (d0) the mutant cells contained less amount of Ezh1 mRNA than the 
wild type. Consequently, during neural differentiation the level of Ezh1 and Ezh2 mRNA was 
gradually increasing until d10 in both cultures but in the mutant to a lesser extent. (Figure 
10DE). The expression of Jmj was similar, independently from the presence of Rybp, except at 
undifferentiated stage (d0) (Figure 10F) when the mutant ES cells expressed less Jmj than the 
wild type ES cells. In summary: expression of PRC members was only slightly altered in the 
rybp null mutant. 
 
 
Figure 10 - Gene expression changes of PRC members (Ring1a (A), Ring1b (B), Yy1 (C), 
Ezh1 (D), Ezh2 (E), Jmj (F)) showed slight alteration 
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Relative gene expression analysis of Ring1a (A), Ring1b (B), Yy1 (C), Ezh1 (D), Ezh2 (E), Jmj 
(F) by qRT-PCR showed that PRC function was probably not modified in lack of Rybp. The 
expression of the indicated markers was normalized to Hprt expression. Means are standard 
deviation ± SD. Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** p < 0.01; *** 
p < 0.001). Statistical method: T test type 3. 
 
 
4.4   Major germ layer formation was not impaired in the rybp null mutant embryoid 
bodies 
 
To examine whether the impairment of neural development is a result of defective germ layer 
formation we investigated the formation of mesoderm, endoderm and ectoderm in the absence 
of Rybp. 
During development Gsc (Goosecoid) is highly expressed during gastrulation when mesoderm 
is formed (Blum et al., 1992). In our experimental system expression of mesodermal marker 
Gsc was increased 3x at d7 in both cell lines (Figure 11A) and there was no difference in Gsc 
expression between the cell lines. This coincides with our previous observations when during 
in vitro cardiac differentiation both early mesodermal markers Gsc and Brachyury were 
expressed as expected but the rybp-/- cells were not able to produce contractible cardiomyocytes 
(Ujhelly et al., 2015). This result shows that the lack of Rybp influences differentiation at later 
stages rather then mesoderm formation. 
Next, we investigated proper endoderm formation by measuring the expression of Sox17 (SRY 
(sex determining region Y)-box 17). Sox17 is essential for endoderm differentiation since sox17 
mutant mouse embryos showed deficiency in definitive endoderm formation (Kanai-Azuma et 
al., 2002). The expression of Sox17 increased by d7 in both cell lines (Figure 11B) and there 
was no significant difference in Sox17 expression between the wild type and the null mutant 
cell line. The mutant cells were not defective in endoderm formation. 
Following, we checked the primitive ectoderm formation through monitoring the expression of 
Fgf5 (Fibroblast growth factor 5). Fgf5 is a marker of primitive ectoderm, which will later 
develop into neuroectoderm (Haub and Goldfarb, 1991; Hébert et al., 1991). In our 
experimental system, Fgf5 was induced 40x to 60x in rybp-/- and rybp+/+, respectively, at the 
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early phase of EB formation (d3) and later (d7) declined in both cell lines (Figure 11C). This 
result confirmed that the primitive ectoderm formation was initiated in both cell lines. 
These results showed that the formation of all major germ layers was properly executed in the 
rybp null mutant cell line. 
 
 
Figure 11 – Gene expression changes of germline markers Gsc (mesoderm), Sox17 
(endoderm) and Fgf5 (primitive ectoderm) showed no differences 
Relative gene expression analysis of Gsc (A), Sox17 (B) and Fgf5 (C) by qRT-PCR showed that 
the major germ layer formation was not defective in lack of Rybp. The expression of the 
indicated markers was normalized to Hprt expression. Means are standard deviation ± SD. 
Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** p < 0.01; *** p < 0.001). 
Statistical method: T test type 3. 
 
 
4.5   Lack of Rybp accelerated neural progenitor formation 
 
After examination of germ layer markers, we analyzed the relative gene expression of key early 
neural markers (e.g. Nestin, Pax6, NeuroD1) in both cell lines to gain information whether the 
neuroectoderm formation from the primitive ectoderm is affected in absence of Rybp. 
Nestin is an early marker of neural differentiation and widely employed marker of multipotent 
NSCs of neuroectoderm (Lendahl et al., 1990). Once the cells become differentiated, Nestin 
expression is downregulated (Park et al., 2010). As expected, at the time of neural induction 
(d7, RA treatment), Nestin was strongly upregulated in both cell lines (Figure 12A). Nestin 
expression increased further after plating of the cells (d10) and its level decreased only at later 
phases of neural differentiation (d14) in both cell lines (Figure 12A). Notably, Nestin 
expression was more robust in the rybp-/- cell line compared to the rybp+/+ at d10. 
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Immunocytochemistry with Nestin antibody confirmed the presence of NSCs and NPCs in both 
cell lines with stronger expression in the rybp-/- cells at d10 (Figure 13AC). By the endpoint of 
the experiment (d14) the number of Nestin expressing cells were reduced in both cell lines 
(Figure 13AC). These results suggested that early neural processes took place in a greater extent 
in absence of functional Rybp. 
 
 
Figure 12 - Gene expression analysis showed upregulation of early neural markers (Nestin, 
Pax6, NeuroD1) in the mutant 
Relative gene expression analysis of Nestin (A), Pax6 (B) and NeuroD1 (C) by qRT-PCR 
showed elevated expression of early neural markers in rybp null mutant neural cultures in 
comparison to wild type. The expression of the indicated markers was normalized to Hprt 
expression. Means are standard deviation ± SD. Values of p ˂  0.05 were accepted as significant 
(* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
Pax6 gene is required for the initiation of neural differentiation (Ericson et al., 1997) but later 
it has to be downregulated since its high level inhibits terminal differentiation (Bel-Vialar et 
al., 2007). Relative gene expression analysis revealed that Pax6 was upregulated after the RA 
treatment (d7) (Figure 12B) and its level decreased at later timepoints of neural differentiation 
(d14) in the wild type cells. Expression of Pax6 was higher after neuroectodermal induction in 
the rybp-/- cells compared to the wild type (Figure 12B). Pax6 immunostaining visualized the 
distribution of Pax6 positive cells in the wild type and mutant neural cell cultures (Figure 13B). 
The Pax6 signal was stronger in the mutant cultures in all examined time points (Figure 13BD). 
In both cell lines, the number of Pax6 positive cells was the highest at d10, when early 
differentiation events take place. These results correlate with the data of Pax6 qRT-PCR 
analysis and indicate an abundance of Pax6 positive cell population in the rybp null mutants. 
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Figure 13 - Rybp deficient cells showed impaired protein expression of neural markers 
during in vitro neural differentiation 
Immunocytochemical analysis of in vitro differentiated neural cultures after plating (d10, d14) 
showed altered expression on early neural markers Nestin (A) and Pax6 (B). Both markers 
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showed elevated expression in the mutant. Objective: 60x. Scale bars: 60 µm. Semi-
quantification of Nestin (C) and Pax6 (D) levels and the percentage of immunopositive cells. 
On the left panels vertical axis indicates the intensity of the fluorescence signal of the 
immunopositive cells, on the right panels vertical axis indicates the percentage of the 
immunopositive cells. Means are standard deviation. Values of p ˂ 0.05 were accepted as 
significant (* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
NeuroD1 is a transcription factor, which is essential for terminal neuronal commitment of 
neural progenitors (Boutin et al., 2010). Relative gene expression analysis by qRT-PCR showed 
that NeuroD1 was mildly expressed after RA treatment (d7) in both cell lines (Figure 12C). The 
expression level of NeuroD1 was significantly higher at early stage (d10) in the mutant cell line 
compared to the wild type. The expression of NeuroD1 decreased by the end of differentiation 
(d14) in the rybp-/- cells whilst there was only a minor decrease in its level in the rybp+/+ cells. 
At d14, NeuroD1 expression was higher in the wild type cells compared to the mutants. This 
also confirmed that the characteristics of NPCs were altered in the rybp null mutants: the 
premature differentiation of NPCs was accelerated at the mid-phase (d10) but it was attenuated 
by the end of differentiation (d14). 
 
 
4.6   Absence of Rybp obscured terminal differentiation of neural lineages 
 
After examining the early markers of neural differentiation, we analyzed the relative gene 
expression of key late neural markers (e.g. Tubb3, NeuN, Gfap, Olig2) to clarify whether the 
formation of mature neural cell types (neurons, astrocytes, oligodendrocytes) is defective in the 
rybp null mutant cells. 
Tubb3 is a well-known neuronal cell marker, which contributes to the microtubule stability in 
axons (Black et al., 1984). It plays a critical role in proper axon guidance, maintenance and 
axonal transport (Ferreira and Caceres, 1992) and is also expressed in the postmitotic phase of 
differentiating neurons (Fanarraga et al., 1999). Relative gene expression analysis by qRT-PCR 
showed that Tubb3 expression was elevated at early stage (d10) in both cell lines but its 
expression declined in the rybp-/- cells at later stage of neural differentiation (d14) while its 
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level remained high in the wild type (Figure 14A). In order to visualize the developing network 
of neural cell culture spatiotemporally we stained the cells with Tuj1 antibody, which marks 
Tubb3 positive cells. The assessment of Tuj1 staining (Figure 15AC) showed that neurite 
processes and axon-like structures started to develop in both cell lines, however, the rybp+/+ 
outgrowths exhibited a more complex and dense network than the mutants. The reduced density 
of nerve fibers by ICC in the rybp null mutant cell line was consistent with the data on 
diminished amount of nerve bundles on Tubb3 by qRT-PCR analyses. These data suggest that 
a normal level of Rybp is important for the proper development of neurons. 
 
 
Figure 14 - Gene expression changes of markers of late neural differentiation (Tubb3, NeuN, 
Gfap, Olig2) showed terminal differentiation deficiency 
Relative gene expression analysis of Tubb3 (A), NeuN (B), Gfap (C) and Olig2 (D) by qRT-
PCR showed that late neural markers were downregulated in rybp null mutant neural cultures 
compared to wild type. The expression of the indicated markers was normalized to Hprt 
expression. Means are standard deviation ± SD. Values of p ˂  0.05 were accepted as significant 
(* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
In order to confirm the presence of mature neurons in our cell cultures we assessed the relative 
gene expression changes of postmitotic neuronal marker NeuN, which marks the nuclei of 
maturing and differentiated neurons (Mullen et al., 1992). As expected, qRT-PCR analysis 
showed that NeuN was abundantly expressed in the plated wild type neural cultures (d10, d14) 
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but its level stayed constantly low in the mutants (Figure 14B). This indicated that much less 
mature neurons formed in the rybp null mutant culture (d10, d14) and further confirmed the 
compromised differentiation ability of rybp null NPCs. 
This observation tempted us to speculate whether this defect is specific to neurons or other cell 
types like astrocytes and oligodendrocytes are also affected in the absence of Rybp. Therefore, 
we next analyzed whether cells lacking functional Rybp are able to generate astrocytes as well. 
In order to do so, we had performed relative gene expression analysis by qRT-PCR in both cell 
lines for Gfap, which is a commonly accepted intermediate filament marker of radial glias and 
astrocytes (Bignami et al., 1972; Eng et al., 1971). Our analysis revealed that the level of Gfap 
was elevated over 300x in the wild type cells (Figure 14C; d14). In comparison its level stayed 
low in the rybp null mutants (Figure 14C; d14). We also analyzed the spatial distribution of 
Gfap by immunostaining and found that there was no Gfap positive cell in the mutant neural 
cultures (Figure 15BD). This suggested that the astrocyte differentiation was also defective in 
the mutant cells. 
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Figure 15 - Rybp deficient cells showed impaired protein expression of late neural markers 
during in vitro neural differentiation 
Immunocytochemical analysis of in vitro differentiated neural cultures after plating (d10, d14) 
showed altered expression on neural cell marker Tuj1 (A), which expressed in axon of maturing 
neurons and in postmitotic neurons. (B) Immunostaining of astrocyte marker, Gfap showed a 
small amount of astrocyte-like cells in wild type culture, which was absent in the mutant. Both 
markers were nearly invisible in the rybp-/- cell culture at d14 compared to wild type, which 
indicated defects in late neural processes. Objective: 60x. Scale bars: 60 µm. Semi-
quantification of Tuj1 (C) and Gfap (D) levels and the percentage of immunopositive cells. On 
the left panels vertical axis indicates the intensity of the fluorescence signal of the 
immunopositive cells, on the right panels vertical axis indicates the percentage of the 
immunopositive cells. Means are standard deviation. Values of p ˂ 0.05 were accepted as 
significant (* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
We also investigated if the absence of Rybp has influence on other types of glial cells or it is 
specific for astrocytes. For this purpose, we measured the relative expression level of Olig2 by 
qRT-PCR. Olig2 is a marker gene for oligodendrocytes (Mizuguchi et al., 2001; Takebayashi 
et al., 2002; Zhou et al., 2000). Oligodendrocyte differentiation normally started by d7 and 
peaked by d14 (Figure 14D rybp+/+). In contrast, the rybp-/- cells expressed 60x less Olig2 
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mRNAs at d14 compared to the wild type (Figure 14D). This demonstrated that 
oligodendrocyte differentiation was also strongly impaired in the absence of functional Rybp. 
 
 
4.7   Dendrite and axon formation was impaired in the absence of Rybp 
 
Next, we wanted to specify the nature of the defective neural differentiation so we investigated 
the formation of dendrite and axon formation with lineage specific markers. 
In mature neurons Map2 (Microtubule-associated protein 2) is preferentially localized to 
dendrites (Caceres et al., 1984), whereas Tau (also known as MapT (Microtubule-associated 
protein tau) or τ) labels axons (Kosik et al., 1986; Paglini et al., 2000). Relative expression 
changes of Map2, evaluated with qRT-PCR, revealed that its expression peaked by d10 (400x) 
and remained high in the wild type neural cultures (d14, 250x) but stayed low in the mutant 
(Figure 16A). Expression of Tau mRNAs was the highest by d14 in the wild type (55x), but its 
level was nearly absent in the mutant (Figure 16B). 
 
 
Figure 16 - Gene expression changes of dendritic (Map2) and axonal (Tau) markers showed 
alteration in lack of Rybp 
Relative gene expression analysis of Map2 (A) and Tau (B) by qRT-PCR showed decreased 
expression of dendritic and axonal markers in rybp null mutant neural cultures compared to 
wild type. The expression of the indicated markers was normalized to Hprt expression. Means 
are standard deviation ± SD. Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** p 
< 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
We co-stained Map2, with NSC marker RC2, and Tau, with neurofilament marker 2H3 to 
visualize the spatiotemporal distribution of the dendrites and axons in our neural cell cultures. 
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We observed RC2-positive, 2H3-positive, Map2-positive and Tau-positive cells in each cell 
cultures, which indicated that both early neural progenitors and mature neuronal cells were 
present in both cell lines at the examined timepoints (Figure 17). The number of RC2 positive 
cells was higher in the mutant at both timepoints, which is in accordance with the results of the 
Nestin staining (Figure 13AC) and the Nestin qRT-PCR (Figure 12A). The number of 2H3 
positive cells was lower in the mutant at d14 with a weaker signal, which is in accordance with 
Tuj1 results (Figure 13AC). Map2 and Tau staining showed that there were persistently more 
axonal and dendritic cells present at later timepoint (d14) in the wild type compared to the 
mutant. The formation of dendrites and axons from existing neural progenitors was defective 
in the absence of Rybp. 
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Figure 17 – Rybp deficient cells showed altered dendrite and axon formation through in vitro 
neural differentiation 
(AB) Immunocytochemical analysis of in vitro differentiated neural cultures after plating (d10, 
d14) showed altered expression on neural progenitor marker RC2 (A)(red), neurofilament 
marker 2H3 (B)(red), dendrite specific marker Map2 (A)(green) and axonal marker Tau 
(B)(green). While RC2 showed elevated expression in the mutant compared to the wild type, the 
number of Map2 positive, 2H3 positive and Tau positive cells was lower. Objective: 60x. Scale 
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bars: 60 µm. Semi-quantification of Map2 (C), RC2 (D), Tau (E) and 2H3 (F) levels and the 
percentage of immunopositive cells. On the left panels vertical axis indicates the intensity of 
the fluorescence signal of the immunopositive cells, on the right panels vertical axis indicates 
the percentage of the immunopositive cells. Means are standard deviation. Values of p ˂ 0.05 
were accepted as significant (* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T 
test type 3. 
 
 
4.8   Plagl1 was not induced in the rybp-/- cells during in vitro neural differentiation 
 
Based on the marked alterations in gene expression described above (Sox2, Pax6, Nestin, 
NeuroD1, Tubb3, NeuN, Gfap, Olig2, Map2, Tau) we had performed genome wide profiling 
by transcriptome analysis and compared the gene expression profile of the wild type and rybp 
null mutant ES cells (d0). We were wondering whether there is any gene, which expression 
level is influenced by the lack of Rybp. We paid special attention towards genes being important 
for neural differentiation. Several transcripts expressed differently in the two ES cell lines 
(Appendix C, Table S2, S3). One of the most downregulated genes in rybp null ES cells was 
Plagl1 (d0: fold change = -13.86, padj=2.3·10-5; the level of Plagl1 was 13.86x lower in the 
mutant compared to wild type and this change is significant), which gene has crucial role in 
mouse embryonic development (Chung et al., 2011; Ma et al., 2007; Valente and Auladell, 
2001; Valente et al., 2005; Varrault et al., 2006; Yuasa et al., 2010). 
To further investigate if Rybp impacts Plagl1 expression only in ES cells or the deficiency is 
sustained through the course of neural differentiation, we had checked the expression changes 
of Plagl1 mRNAs during in vitro neural differentiation of rybp+/+ and rybp-/- ES cells. Gene 
expression analysis by qRT-PCR (Figure 18A) revealed that Plagl1 was strongly induced 
(300x) after the RA treatment (d7) during in vitro neural differentiation in the wild type cells 
and remained high until the end of differentiation (d14). However, in the rybp-/- cells Plagl1 
was not induced during the entire course of differentiation. After this, we wanted to test whether 
the difference in Plagl1 mRNA induction is also sustained at protein level. In order to visualize 
the spatiotemporal distribution of Plagl1 throughout the differentiation we performed 
immunocytochemistry of in vitro neural cultures with antibody against the Plagl1 protein 
 45 
(Figure 18BC). This confirmed that Plagl1 was visible in the nuclei of the wild type cells 
(Figure 18B; rybp+/+ d10, d14) while in the rybp-/- cells there is a complete lack of Plagl1 
expression. These results showed that Plagl1 was absent in rybp-/- cells during the entire course 
of neural differentiation and they were in agreement with our recent observation, that Plagl1 
was not induced during in vitro cardiac differentiation of rybp-/- ES cells (Ujhelly et al., 2015).  
 
 
 
Figure 18 – Rybp null mutant cells did not show Plagl1 expression 
(A) Relative gene expression analysis by qRT-PCR showed that Plagl1 induction was deficient 
in the null mutant cells. The expression of Plagl1 was normalized to Hprt expression. Means 
are standard deviation ± SD. Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** p 
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< 0.01; *** p < 0.001). Statistical method: T test type 3. (B) Immunocytochemistry with 
antibody against Plagl1 revealed that Plagl1 was expressed in the nucleus of rybp+/+ cells but 
it was completely absent in rybp-/- cells. Objective: 60x. Scale bar: 60 µm. Semi-quantification 
Plagl1 (C) level and the percentage of immunopositive cells. On the left panel vertical axis 
indicates the intensity of the fluorescence signal of the immunopositive cells, on the right panel 
vertical axis indicates the percentage of the immunopositive cells. Means are standard 
deviation. Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** p < 0.01; *** p < 
0.001). Statistical method: T test type 3. 
 
 
4.9   Lack of Rybp did not effect cell-cycle distribution but altered apoptosis 
 
It was previously described that Plagl1 promotes cell-cycle withdrawal (Valente and Auladell, 
2001) and has important function in apoptosis (Spengler et al., 1997). Since Rybp is also 
involved in regulation of apoptosis (Stanton et al., 2007; Zheng et al., 2001) and we had no 
information about the context of cell-cycle progress we have measured the distribution of cell-
cycle phases and the rate of apoptosis in wild type and rybp null mutant cells during neural 
differentiation by FACS analysis (described in Materials and methods). In brief, we incubated 
the cells with BrdU for 1h, fixed with ethanol, denatured with HCl, neutralized with Na2B4O7, 
permeabilized with Tween20, then the cells were incubated with the primary monoclonal 
antibody anti-BrdU, then with Alexa Fluor® 647–labeled secondary antibody. The cells were 
resuspended in propidium-iodide (PI), then FACS analysis was performed. 
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Figure 19 –Cell-cycle changes in rybp+/+ and rybp-/- ES cells during neural differentiation 
There were no significant differences in the distribution of cell-cycle phases during neural 
differentiation between wild type (A) and rybp null mutant (B) cells. Means are standard 
deviation. Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** p < 0.01; *** p < 
0.001). Statistical method: T test type 3. 
 
In the course of in vitro neural differentiation, as expected, the number of cells in S phase was 
gradually decreasing, while concomitantly the number of cells in G1 phase was increasing in 
the wild type (Figure 19). Our results showed that the distribution of cell-cycle phases was near 
identical in the mutant. This suggested that withdrawal of Rybp from the cells had no significant 
effect on cell-cycle progression during neural differentiation. 
 
 
Figure 20 – Rate of apoptosis in differentiating rybp+/+ and rybp-/- cells 
Apoptosis determined during neural differentiation of wild type and rybp null mutant cells by 
PI staining and FACS analysis. In the mutant culture the number of apoptotic cells was higher 
at d7 and d10 compared to the wild type. Vertical axis shows the percentage of apoptotic cells. 
Means are standard deviation. Values of p ˂ 0.05 were accepted as significant (* p < 0.05; ** 
p < 0.01; *** p < 0.001). Statistical method: T test type 3. 
 
We also examined the rate of apoptosis in both cell cultures by FACS analysis of PI stained 
nuclei of differentiating cells. Our results showed that there were differences in the rate of 
apoptosis during neural differentiation between wild type and rybp null mutant cell lines. The 
number of apoptotic cells was higher in the mutant at d7 and d10 (Figure 20) compared to wild 
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type, 11.5% compared to 7%, and 3.7% compared to 1.9%, respectively. It seems that the lack 
of Rybp has no affect on cell-cycle, but influences apoptosis during in vitro neural 
differentiation. 
 
 
4.10   Rybp was able to activate Plagl1 through its promoter 
 
Some of the developmental defects of Plagl1 mutant mice (Chung et al., 2011; Yuasa et al., 
2010) are strikingly similar to the phenotype of the rybp+/- mice (including defects of neural 
tube closure, defects in cortex and cerebellum development) (Figure 4) (Pirity et al., 2005). In 
addition, Rybp can regulate through E2f (E2 promoter binding factor) binding sites (Schlisio 
et al., 2002; Trimarchi et al., 2001), which are also present in Plagl1 promoter. These raise the 
possibility that Rybp can regulate Plagl1 promoter, so we examined this possibility with 
luciferase reporter assay. 
We used Plagl1 gene promoter luciferase reporter construct (pGL3.Plagl1-Luc) and HA-tagged 
Rybp vector (pcDNA3.1-RybpHA) to evaluate the transactivational potency of Rybp to Plagl1 
expression. Rybp expression vectors were cotransfected at different dosages (1 µg, 5 µg, 25 
µg) with Plagl1 promoter constructs into COS7 cells, then after two days luciferase activity was 
measured from the cell lysates. Our results showed that Rybp activated the Plagl1 promoter 
more than 1500 fold (Figure 21). This induction was up to 5 fold if it was compared to the basic 
activity of the Plagl1 vector. The fold increase was similar at cotransfections of different 
dosages of Rybp vectors with Plagl1 promoter construct. In our experiments Rybp could 
activate Plagl1 promoter and this effect was unlikely dosage dependent. 
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Figure 21 – Rybp activated Plagl1 gene expression through its promoter  
COS7 cells were transfected with Rybp expression plasmid in increasing dosages (1 µg, 5 µg, 
25 µg) and with Plagl1 promoter luciferase reporter construct. Luciferase activity of the 
transfected cell lysates were measured 48 hours after transfection. Values were expressed as 
fold increase in luciferase activity. Results showed that cotransfection of Plagl1 vector with 
Rybp vector increased luciferase activity, which indicated that Rybp activated Plagl1 
expression through its promoter. Means are standard deviation. Values of p ˂ 0.05 were 
accepted as significant (* p < 0.05; ** p < 0.01; *** p < 0.001). Statistical method: T test type 
3. 
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5.   DISCUSSION 
 
 
The current thesis aimed to elucidate the molecular events underlying of the rybp heterozygous 
mice phenotype (Pirity et al., 2005) and to investigate the role of PcG protein Rybp in neural 
lineage specification. Considerable attention has focused on the characterization of ES cell 
derived neural lineages in the absence of functional Rybp. The contribution of Rybp to neural 
lineage commitment is particularly interesting since in vivo evidence has been already provided 
that Rybp is important for neural development and it is broadly expressed in different cell types 
of the CNS. Furthermore, misexpression of PRC members has been associated with a broad 
range of cancers, suggesting that they have essential role in maintaining cell identity and disease 
development. Downregulation of Rybp was shown in glioblastomas and other types of tumors 
and overexpression of Rybp inhibited tumor growth of liver cancer cells and sensitized them 
for consequent chemotherapy treatment in vivo (Chen et al., 2009; Li et al., 2013; Novak and 
Phillips, 2008; Taylor et al., 2010; Voruganti et al., 2015; Wang et al., 2014). All of this recent 
observations support that Rybp is a candidate new biomarker for predicting the prognosis of 
cancer patients (Voruganti et al., 2015; Wang et al., 2014). Based on this, a better understanding 
of the processes governed by Rybp is highly desirable. 
 
5.1   Rybp is essential for the development of mature neural cell types 
 
Results from this project broaden our knowledge on the characteristics of stem cells and the 
process of neural differentiation. We found that the formation of NSCs and NPCs is accelerated 
in absence of Rybp, however these cells formed less mature neural cell types from existing 
progenitors than the wild type counterparts. This phenotype cannot be caused by improper 
silencing of key pluripotency genes (e.g., Oct4, Nanog) since our results demonstrated that this 
process is a well-coordinated event in the absence of Rybp during in vitro neural differentiation. 
At the same time, the expression of early neural markers is remarkably altered in rybp-/- cells. 
One of the most important early neural marker, which level is altered in rybp null mutant, is 
Pax6 (Gajović et al., 1997). It is a key transcriptional factor, whose level needs to be upregulated 
at the beginning of neural development since Pax6 plays important role in establishing NPC 
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pool during the vertebrate nervous system development (Ericson et al., 1997). At the same time 
downregulation of Pax6 is also necessary for the forthcoming, late neural differentiation. In our 
assays when Rybp is absent, the level of Pax6 stays elevated. Since high level of Pax6 obstructs 
terminal differentiation of NPCs, it is possible that this “excess” level of Pax6 helps to keep 
NPCs at the early stage of differentiation and inhibits the forthcoming late neural processes in 
the rybp-/- cells (Bel-Vialar et al., 2007) (Figure 23). Upregulation of Nestin and NeuroD1 also 
confirms that early neural processes are accelerated in the lack of Rybp compared to the wild 
type. Nevertheless, the pool of Sox2 positive cells is reduced in the rybp null mutants earlier 
than in the wild type neural cultures. Sox2 is not only a critical factor for maintaining 
pluripotency and directing the differentiation of stem cells to NPCs, but it is also important for 
maintaining the properties of NPCs (Graham et al., 2003). Downregulation of Sox2 resulted in 
progenitor cells led to lose their capability to proliferate and terminally differentiate (Taranova 
et al., 2006). Since others already described that the striking increase of Pax6 can partially 
rescue the Sox2 mutant phenotype (Matsushima et al., 2011), it cannot be excluded that 
increased level of Pax6 in the rybp null mutant compensates the effect of low level of Sox2. It 
is possible that lack of Rybp alters the balance among major transcription factors governing the 
NPC pool generation and consequent differentiation events. By changing the expression level 
of one or more members in these circuits will shift the finely tuned balance and initiate 
premature differentiation. Alternatively, this suboptimal balance may exhaust the NPC pool, 
which obscures consequent differentiation events. Since Rybp is a moonlighting protein, and is 
involved in such diverse biological functions as ubiquitination (Tavares et al., 2012), apoptosis 
(Stanton et al., 2007; Zheng et al., 2001) and transcriptional repression (Schlisio et al., 2002), 
it may have multiple roles in regulating neural differentiation as well. Further complicates the 
situation that Yaf2, the other member of the Rybp/Yaf2 gene family, may compensate the lack 
of Rybp at certain extent (Kaneko et al., 2003; Sawa et al., 2002). 
Importantly, decreased level of late neuronal markers (Tubb3, NeuN, Gfap, Olig2) indicates 
that the maturation of neurons, astrocytes and oligodendrocytes is deficient in the rybp null 
mutant cells (Figure 22) (Kovacs et al., 2016). This results showed that the process of 
differentiation towards all mature neural cell types rather than to a specific lineage is impaired 
in the lack of Rybp. This also supported by the fact that Map2 and Tau expressed at lower 
amount in the mutant compared to wild type and indicates defective formation of axons and 
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dendrites in the rybp null mutant. The formation of neurite processes and their organization into 
complex network is influenced by the presence or absence of Rybp, which brings up the 
possibility that Rybp may have a role in microtubule remodeling during neurite extension. 
These findings are in accordance with previously described in vivo work demonstrating that 
Rybp is a critical factor for CNS development (Gao et al., 2012; Pirity et al., 2007, 2005).  
 
 
Figure 22 - Model of in vitro neural differentiation of ES cells in presence and absence of 
Rybp 
(A) Differentiation of wild type ES cells towards matured cell types of the CNS in the presence 
of Rybp. 
Pluripotent ES cells express key pluripotency markers (e.g. Oct4, Nanog) in undifferentiated 
state, which are gradually decreasing through in vitro neural differentiation. Parallel with this, 
early neural markers (Pax6, Nestin, NeuroD1) are upregulated in NSCs, which will confer 
reduced proliferative and high differentiation capacity to the cells. On the other hand, in the 
presence of Rybp, upregulation of Plagl1 helps to facilitate late neural differentiation and 
inhibits cell proliferation, which will facilitate the generation of terminally differentiated neural 
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cell types (N, OC, AC). By the progression of neural differentiation, NPCs will differentiate 
further and start to express markers of specialized neural cell types (Tubb3, NeuN, Olig2, 
Gfap). 
(B) Differentiation of pluripotent ES cells towards matured cell types of the CNS is impaired in 
the absence of Rybp. 
During neural differentiation early neural markers (Pax6, Nestin) exhibit elevated expression 
level in the rybp null mutants. These will facilitate the generation of an expanded pool of NPCs 
with higher proliferative capacity. On the other hand, in the absence of Rybp, Plagl1 expression 
is defective, which also contributes to the increased proliferative and decreased differentiation 
capacity of the NPCs. As a result, the formation of terminally differentiated neural cell types 
(N, OC, AC) will be impaired in the lack of functional Rybp. 
Abbreviations: ES cell: embryonic stem cell, NSC: neural stem cell, NPC: neural progenitor 
cell, N: neuron, OC: oligodendrocyte, AC: astrocyte, RA: retinoic acid, CNS: central nervous 
system. 
 
5.2   Plagl1 is a downstream target of Rybp 
 
The other gene whose expression is drastically changed in the rybp-/- neural cultures is Plagl1, 
which is an important regulator of neural development (Valente and Auladell, 2001), apoptosis 
and cell-cycle arrest whereas it has antiproliferative and tumor suppressor activity (Abdollahi 
et al., 1997; Spengler et al., 1997). We found that Plagl1 is absent both in rybp-/- cardiac (Ujhelly 
et al., 2015) and neural cultures (Kovacs et al., 2016) which suggests that this deficiency is not 
cell-lineage specific. The observation that Plagl1 is completely downregulated in the absence 
of functional Rybp and the fact that Rybp and Plagl1 deficient mice exhibit similar 
developmental defects indicates a possible genetic or biochemical link between Rybp and 
Plagl1 (Chung et al., 2011; Pirity et al., 2005; Yuasa et al., 2010). Furthermore, Farhy et al. 
reported that Plagl1 is downregulated in the Pax6 deficient cells (Farhy et al., 2013). In this 
study increased level of Pax6 accompanied by the downregulation Plagl1 in Rybp deficient 
cells. In the absence of functional Rybp it is very likely that the balance of early and late neural 
processes is “unbalanced”, which is probably linked to the upregulation of Pax6 and the loss of 
Plagl1 (Figure 22). This study is pinpointing a possible connection among a transcriptional 
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circuit of Rybp, Plag1 and Pax6. 
It is also known that Plagl1 promotes cell-cycle withdrawal of NPCs during the differentiation 
processes (Valente and Auladell, 2001). The tight regulation of cell-cycle is required to ensure 
timely generation and correct amount of the various neural cell types, which largely depends 
on the presence of Plagl1. We did not observe differences in the distribution of cell-cycle phases 
through the course of neural differentiation between rybp+/+ and rybp-/- cells suggesting that 
Rybp may exert its function via a cell-cycle independent manner. Besides cell-cycle, apoptosis 
also contributes to establishing the complexity of CNS and helps to eliminate the excessive 
cells (Brill et al., 1999; Zakeri and Lockshin, 2002). During neural differentiation Plagl1 also 
mediates apoptosis independently of its cell-cycle arresting function (Spengler et al., 1997). In 
differentiating rybp-/- cells we found an increased rate of apoptosis compared to the wild type. 
At d7 and d10, when the rate of apoptosis is elevated in the mutant, the formation of NSCs is 
also extended compared to the wild type cultures. It is possible that a portion of the cells 
undergo apoptosis instead of differentiating into mature neural cell types and this may be 
resulted from the absence of Plagl1 and Rybp. 
Results from luciferase reporter assay revealed that Rybp can activate the Plagl1 promoter. The 
promoter of Plagl1 contains three E2f binding sites, which are together with Yy1 sites may well 
serve as anchoring sites for an Rybp mediated transcriptional regulation process (Figure 23). 
This leaves open the possibility that Rybp regulates Plagl1 via an E2f dependent mechanism. 
 
5.3   Rybp may exert its biological functions via biochemically heterogenic multimeric 
complexes 
 
Possibilities for action of Rybp are likely very diverse. Recent studies showed that Rybp is a 
member of the recently identified ncPRC1 complex (Figure 23) (Chen and Dent, 2014; Farcas 
et al., 2012; He et al., 2013; Oliviero et al., 2015; Schwartz and Pirrotta, 2013; Turner and 
Bracken, 2013). Previous studies highlighted the importance of PRC members in neural 
development. Loss of Ring1b, which is a core member of the ncPRC1 and binding partner of 
Rybp (Figure 23), caused premature neural differentiation (Román-Trufero et al., 2009). 
PRC1.1 complex member Kdm2b (Lysine (K)-specific demethylase 2b; also known as Fbxl10 
(F-box and leucine-rich repeat protein 10)) has essential function during embryonic 
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development (Gearhart et al., 2006). Notably, loss of Kdm2b is perinatally lethal with 
incomplete neural tube closure, exencephaly, and altered cell-cycle processes in NPCs (Fukuda 
et al., 2011) partially mimicking the phenotype of the heterozygous rybp mice (Pirity et al., 
2005). PRC1.4 member Pcgf4 (Polycomb group ring finger 4, also known as Bmi1 (B 
lymphoma Mo-MLV insertion region 1 homolog)) has important role in neural development 
since bmi1 mutant mice showed neurological defects (Van Der Lugt et al., 1994). 
 
 
Figure 23 – Rybp is a member of the non-canonical PRC1 complexes 
In all different ncPRC1 complexes Rybp binds a Ring protein (Ring1a or Ring1b) and a Pcgf 
protein. PRC1.1 complex encompasses Pcgf1, Bcor, Skp1 or Usp7, and Kdm2b. In PRC1.2 
complex Rybp and Ring1a/Ring1b bind Pcgf2 (Mel18) and E2f6. In PRC1.4 complex Rybp and 
Ring1a/Ring1b bind Pcgf4 (Bmi1) and E2f6. PRC1.6 encompasses Pcgf6, E2f6, Cbx3 and 
L3mbtl2. E2f2, E2f3, E2f6 and Yyi1 can interact with Rybp. 
 
Other PRC members and interactors are also important for neural development: complete lack 
of Yy1, binding partner of Rybp, is manifested in embryonic lethality, while heterozygote 
embryos exhibit neurulation defects (Donohoe et al., 1999); and the jmj null mutants show 
neural tube closure defect (Takeuchi et al., 1995). Ezh2, a core member of the PRC2, is highly 
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expressed in NPCs and is downregulated through the differentiation of mature cortical neurons 
(Sparmann et al., 2013). Notably, Neurogenin 1, has been found to be suppressed by a PRC 
mediated mechanism at the neuronal-to-astrocytic transition of NPC differentiation during 
corticogenesis (Testa, 2011). 
In our experimental system, the expression level of PRC1 and PRC2 members does not show 
great alteration during in vitro neural differentiation. We do not necessary expect compositional 
or gene expression changes at the PRC members since withdrawing one member does not 
necessary have effect on the whole complex, however it is possible that these complexes cannot 
function properly when Rybp is absent. Nevertheless, we cannot exclude the possibility that 
Rybp is functioning as a member of other multimeric complexes during different steps of neural 
development, so it is possible that the function of Rybp during neural differentiation is not PRC 
mediated. We assume that Rybp, independently from its polycomb function, can activate 
Plagl1. To our knowledge, Rybp has never been described previously as an activator. To clarify 
whether Rybp is functioning as member of PRCs or other multimeric protein complexes during 
neural development is a debate of further studies.  
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6.   SUMMARY 
 
 
In current thesis I have investigated the function of the non-canonical PRC1 member, Rybp 
during neural lineage commitment. For this purpose, we utilized wild type and rybp null mutant 
ES cells and differentiated them in vitro into neural lineages. Our results showed that the 
formation of NSCs and NPCs was excessive in the rybp null mutant compared to the wild type, 
however they cannot form matured neural cell types properly. The absence of Rybp caused 
alteration in expression of key neural markers (Nestin, Tubb3, Gfap, Map2, Tau) and 
transcription factors (Sox2, Pax6, NeuroD1, NeuN, Olig2, Plagl1). The endogenous Plagl1 is 
one of the most downregulated genes suggesting a possible transcription circuit between Rybp, 
Plagl1 and other transcriptional factors. This study demonstrates the importance of Rybp in in 
vitro neural lineage specification. 
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A polikomb fehérje, Rybp kulcsfontosságú az egér embrionális 
őssejtek neurális differenciációjához 
 
Ph.D. értekezés összefoglalója 
 
 
BEVEZETÉS 
 
Őssejtek neurális differenciációja 
 
Az embrionális őssejtekből alakul ki egy felnőtt szervezet minden specializált sejttípusa és 
szövete. A központi idegrendszer kialakulása során, a korai szakaszban a pluripotens 
embrionális őssejtek először multipotens neurális őssejtekké, majd neurális progenitor sejtekké 
differenciálódnak. A neurális differenciáció késői szakaszában ezek a progenitorok érett 
neuronokká, asztrocitákká és oligodendrocitákká fejlődnek. Ezen folyamat több, összetett 
lépésből áll, melyek finoman szabályozottak és zavaruk könnyen idegrendszeri fejlődési 
rendellenességek kialakulásához vezethet. A neurális differenciáció folyamatának 
szabályozásában számos transzkripciós regulátor játszik döntő szerepet. Ezek közül a polikomb 
represszív komplexek jelentős szerepet játszanak a pluripotencia fenntartásában, ugyanakkor 
részt vesznek a differenciáció elindításában a specializációs faktorok repressziójának 
feloldásával. Tézisem, egy ilyen polikomb represszív komplex tagra, az Rybp-re (Ring1 and 
Yy1 binding protein), valamint annak neurális specializációban betöltött szerepére fókuszál. 
 
Az Rybp esszenciális az embrionális fejlődéshez és a központi idegrendszer 
kialakulásához  
 
Csoportunk korábban megállapította, hogy az rybp homozigóta mutáns egerek beágyazódás 
kori letális fenotípust mutatnak, a heterozigótákban pedig az idegrendszer fejlődési 
rendellenességeket (velőcső záródási rendellenesség, exenkefália, stb) figyeltünk meg. Annak 
vizsgálata, hogy az Rybp fehérje teljes hiánya milyen hatással van az idegsejtek kialakulására, 
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a homozigóta egyedek korai letalitása miatt in vivo nem lehetséges, így az Rybp neurális 
differenciációban betöltött szerepét in vitro vizsgáltuk tovább. Vizsgálataim alapját az őssejtek 
azon egyedülálló sajátsága adta, hogy megfelelő feltételek mellett, in vitro körülmények között 
is megtartják pluripotenciájukat és differenciációs képességüket. Az in vitro modellrendszer 
használatával így lehetőségünk nyílt arra, hogy megvizsgáljuk, az Rybp mely differenciációs 
folyamatokban játszik szerepet az idegi fejlődés során. 
 
 
CÉLKITŰZÉSEK 
 
Jelen tanulmány célja az Rybp idegi specializációban betöltött szerepének karakterizálása. 
 
Munkánk során a következőkre fordítottunk kiemelt figyelmet: 
- megvizsgáltuk, hogy az rybp homozigóta mutáns őssejtek képesek-e a fő idegi 
sejttípusokat (neuronok, oligodendrociták, asztrociták) kialakítani. 
- leírtuk az rybp homozigóta mutáns őssejtekből differenciálódott neurális prekurzor 
sejtek jellegzetességeit, külön figyelmet fordítva a megújulási és differenciációs 
képességükre. 
- meghatároztuk, hogy mely érett neurális formák képzése zavart az Rybp hiányában. 
- célunk volt olyan géneket találni, melyek az Rybp „downstream” célgénjei és 
expressziójuk megváltozik az Rybp hiányában vagy jelenlétében a neurális 
differenciáció során. 
 
 
ALKALMAZOTT MÓDSZEREK 
 
Őssejtek in vitro neurális differenciációja 
 
Vad típusú (rybp+/+) és Rybp-t nem expresszáló, homozigóta mutáns (rybp-/-) őssejtvonalak 
fenntartása zselatinnal felületkezelt sejttenyésztő csészében zajlott. A neurális differenciációt 
Bibel és csoportja, 2004-ben megjelent közleménye alapján végeztük, kisebb módosításokkal. 
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Az őssejtekből szuszpenziós kultúrában három dimenziós aggregátumokat (úgynevezett 
“embrionális testecskék”) hoztunk létre, a negyedik napon retinsavval indukáltuk a 
neuroektoderma feldúsulását, majd az embrionális testecskék disszociációját követően, a 
sejteket azonos számban, felületkezelt sejttenyésztő edényekbe helyeztük. A letapasztott 
sejteket 6 napon keresztül tenyésztettük. További analízis céljából mintavétel történt a 0., 3., 7., 
10. és 14 napokon. 
 
Morfológiai analízis 
 
A mintavételi időpontokban a differenciálódó sejtek morfológiai analízisét a következőképp 
végeztük: a paraformaldehiddel fixált őssejtekről (0.nap) és embrionális testekről (3. nap, 7. 
nap), valamint a kristály ibolyával festett, letapasztott neurális kultúrákról (10. nap, 14. nap) 
Olympus CellR mikroszkóppal készítettünk fénymikroszkópos képeket. A fixált embrionális 
testekről készült, hematoxilinnal és eozinnal festett szekciókat elemezve vizsgáltuk a bennük 
kialakuló struktúrákat. 
 
Molekuláris analízis 
 
A minták génexpressziós analízise kvantitatív valós idejű polimeráz láncreakció (qRT-PCR) 
segítségével történt. Ennek során pluripotencia faktorok, polikomb represszív komplex tagok, 
csíralemez markerek és neurális markerek relatív génexpresszióját vizsgáltuk a differenciáció 
során a két sejtvonalban. A fehérjekifejeződési mintázat analízisét immuncitokémia 
segítségével végeztük, melynek során neurális markerek fehérje szintű kifejeződését, illetve 
annak mintázatát tanulmányoztuk letapasztott neurális kultúrákban. 
 
Sejtciklus analízis és apoptózis szintjének mérése áramlási citometriával 
 
A feltüntetett időpontokban a sejteket bromodeoxiuridinnel kezeltük, majd a megfelelő 
előkészítés után propídium-jodiddal inkubáltuk. A differenciáció során a különböző 
sejtciklusokban tartózkodó, valamint az apoptózison átesett sejtek számát fluoreszcencia-
aktivált áramlási citométer segítségével állapítottuk meg. 
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Luciferáz riporter assay 
 
COS7 sejtekbe CaPO4 transzfekcióval juttattunk Rybp-t tartalmazó, valamint a Plagl1 gén 
promóterét tartalmazó luciferáz riporter konstrukt plazmidokat különböző koncentrációkban. 
A transzfekció után 48 órával a sejteket lizáltuk, majd luciferáz riporter assay kit használatával, 
luminométer segítségével, megmértük a sejtlizátumokban a luciferáz aktivitást. 
 
 
EREDMÉNYEK ÖSSZEFOGLALÁSA 
 
- az rybp homozigóta mutáns őssejtek képesek voltak embrionális testeket képezni, de a 
neurális irányba való differenciációjuk zavart szenvedett. Morfológiai vizsgálatok 
kimutatták, hogy a mutáns őssejtekből létrehozott embrionális testekben nagyobb 
számban képződtek „neurális rozetta-szerű” struktúrák, a letapasztott kultúrában pedig 
a mutáns sejtek kevésbé összetett neurális hálózatot alkottak, mint a vad típusú sejtek.  
- a differenciálódó rybp homozigóta mutáns sejtekben a pluripotencia faktorok ugyanúgy 
megfelelően lecsengtek, mint a vad típusú differenciálódó sejtekben. 
- a neurális differenciáció során egyes polikomb komplex tagok (Ring1a, Ring1b, Ezh1, 
Ezh2) és egyes szabályozó faktoraik (Yy1, Jmj) expressziójában nem volt jelentős 
különbség a két sejtvonalat összehasonlítva. 
- az rybp homozigóta mutáns embrionális testekben mindhárom fő csíralemez 
(endoderma, mezoderma, ektoderma) megfelelően kifejlődött, csakúgy, mint a vad 
típusú embrionális testekben. 
- a korai neurális folyamatok markerei (Pax6, Nestin, NeuroD1) magasabb expressziót 
mutattak az Rybp hiányában, mint jelenlétében a differenciálódó sejtekben. Az 
immuncitokémiai analízis eredményei azt mutatták, hogy a mutáns kultúrákban mind 
az expresszió mértéke, mind az immunpozitivitást mutató sejtek száma magasabb volt. 
- a késői neurális markerek (Tubb3, NeuN, Gfap, Olig2), továbbá az axonális és 
dendritikus markerek (Tau, Map2) csökkent expressziós szintet mutattak a mutáns 
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neurális kultúrákban a vad típushoz viszonyítva, valamint a neurális nyúlványok 
képzésének zavarát is észleltük. 
- a génexpressziós eredmények azt mutatták, hogy a Plagl1 transzkripciós faktor nem 
expresszálódott az Rybp hiányában a neurális differenciáció teljes folyamata során. 
- a neurális differenciáció során a különböző sejtciklusokban található sejtek eloszlásában 
nem volt különbség a két sejtvonal között, tehát az Rybp hiánya nem okozott változást 
a sejtciklusban. 
- az Rybp hiányában több sejt vett részt az apoptózis folyamatában a neurális folyamatok 
során. 
- a luciferáz riporter assay eredményei arra utalnak, hogy az Rybp képes volt aktiválni a 
Plagl1 gént a promóterén keresztül. 
 
 
KONKLÚZIÓ 
 
Munkám során az Rybp neurális differenciációs folyamatokban betöltött szerepét vizsgáltam. 
Ennek során vad típusú és rybp homozigóta mutáns őssejtek in vitro neurális indukcióját 
alkalmaztam. Bár a mutáns őssejtek képesek voltak embrionális testeket képezni, azon belül 
csíralemezeket formálni, majd neurális őssejteket és neurális prekurzorokat képezni; az érett 
neuronok, asztrociták és oligodendrociták képzése zavart szenvedett. Eredményeink 
rámutatnak arra, hogy az rybp homozigóta mutáns neurális progenitorokból kisebb mértékben 
képződnek érett neurális formák, a defektus a neuronokat, az asztrocitákat és az 
oligodendrocitákat is érinti. Megfigyeltük még a Plagl1 teljes hiányát az rybp homozigóta 
mutáns sejtekben, amely arra mutat rá, hogy a Plagl1 az Rybp egyik „downstream” célgénje, 
valamint feltételezhető, hogy az Rybp, a Plagl1 és más transzkripciós faktorok egy közös 
szabályozó útvonal tagjaiként fejtik ki hatásukat. Ezek alapján elmondható, hogy az Rybp 
esszenciális szerepet játszik a neurális specializáció folyamatában. 
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Short ID Entrez gene name Unigene ID number 
MGI ID 
number 
Ezh1 Enhancer of zeste homolog 1 5027 1097695 
Ezh2 Enhancer of zeste homolog 2 246688 107940 
Fgf5 Fibroblast growth factor 5 5055 95519 
Gfap Glial fibrillary acidic protein 1239 95697 
Gsc Goosecoid 129 95841 
Hprt Hypoxanthine phosphoribosyltransferase 1 299381 96217 
Jmj Jumonji 25059 104813 
Map2 Microtubule-associated protein 2 256966 97175 
Nanog Nanog homeobox 485537 1919200 
Nes Nestin 331129 101784 
NeuN Neuronal nuclei 341103 106368 
NeuroD1 Neurogenic differentiation 1 4636 1339708 
Oct4 Octamer-binding protein 4 17031 101893 
Olig2 Oligodendrocyte transcription factor 2 37289 1355331 
Pax6 Paired box 6 33870 97490 
Plagl1 Pleiomorphic adenoma gene-like 1 287857 1100874 
Ring1a Ring finger protein 1 20343 1101770 
Ring1b Ring finger protein 2 474038 1101759 
Rybp Ring1 and Yy1 binding protein 321633 1929059 
Sox2 SRY (sex determining region Y)-box 2 65396 98364 
Sox17 SRY (sex determining region Y)-box 17 279103 107543 
Tau Tau 1287 97180 
Tubb3 Tubulin, beta 3 class III 40068 107813 
Yy1 Yin and yang 1 protein 3868 99150 
 
Table S1 
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increase    
ID Entrez Gene Name Fold Change False Discovery Rate (q-value) 
Car12 Carbonic anhydrase XII 52,000 1,42E-02 
Fam213a Family with sequence similarity 213, member A 6,559 3,39E-03 
Hmgn3 High mobility group nucleosomal binding domain 3 9125,000 1,01E-02 
Mov10l1 Mov10 RISC complex RNA helicase like 1 6,090 1,74E-02 
P4ha2 Prolyl 4-hydroxylase, alpha polypeptide II 9,708 1,74E-02 
Piwil2 Piwi-like RNA-mediated gene silencing 2 8,906 1,37E-02 
Six1 SIX homeobox 1 75,000 1,74E-02 
Stk31 Serine/threonine kinase 31 7,568 1,66E-02 
Tbx3 T-box 3 4,634 5,96E-03 
Tdrkh Tudor and KH domain containing 8,429 7,09E-03 
Tex11 Testis expressed 11 39,500 7,13E-06 
Tex15 Testis expressed 15 9,000 2,72E-03 
 
Table S2 
 
decrease    
ID Entrez Gene Name Fold Change False Discovery Rate (q-value) 
Clca4 Chloride channel calcium activated 4 -10,000 1,86E-03 
Ddx3y DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked -6,269 1,74E-02 
Dnmt3l DNA (cytosine-5-)-methyltransferase 3-like -4,617 4,08E-03 
Esrp1 Epithelial splicing regulatory protein 1 -6,000 2,37E-03 
Fgfr2 Fibroblast growth factor receptor 2 -7,629 9,76E-06 
Grhl2 Grainyhead-like 2 (Drosophila) -6,732 1,82E-02 
Gstm2 Glutathione S-transferase mu 1 -22,000 3,14E-02 
Ina Internexin neuronal intermediate filament protein, alpha -5,525 1,68E-02 
Klhl13 Kelch-like family member 13 -7,107 3,20E-07 
Lrp2 Low density lipoprotein receptor-related protein 2 -4,360 3,14E-02 
Meg3 Maternally expressed 3 -14,510 2,30E-10 
Pax6 Paired box 6 -16,727 9,76E-06 
Plagl1 Pleiomorphic adenoma gene-like 1 -13,862 2,38E-05 
Ptch1 Patched 1 -6,344 1,43E-05 
Rybp Ring1 and Yy1 binding protein -154,000 1,00E-12 
Thbs1 Thrombospondin 1 -9,294 2,17E-02 
Tpm1 Tropomyosin 1, alpha -3,190 2,76E-02 
Trim36 Tripartite motif containing 36 -70,000 8,41E-03 
Uty Ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome -6,976 1,64E-02 
Wt1 Wilms tumor 1 -7,667 1,74E-02 
 
Table S3 
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Rybp (Ring1 and Yy1 Binding Protein) is a transcriptional regulator andmember of the noncanonical polycomb repressive complex
1with essential role in early embryonic development.We have previously described that alteration of Rybp dosage inmousemodels
induced striking neural tube defects (NTDs), exencephaly, and disorganized neurocortex. In this study we further investigated the
role of Rybp in neural differentiation by utilising wild type (푟푦푏푝+/+) and rybp nullmutant (푟푦푏푝−/−) embryonic stem cells (ESCs)
and tried to uncover underlying molecular events that are responsible for the observed phenotypic changes. We found that rybp
null mutant ESCs formed less matured neurons, astrocytes, and oligodendrocytes from existing progenitors than wild type cells.
Furthermore, lack of rybp coincided with altered gene expression of key neural markers including Pax6 and Plagl1 pinpointing a
possible transcriptional circuit among these genes.
1. Introduction
Complex network of transcription factors (TFs) control the
gene expression in the developing embryo thatmanages com-
plex differentiation processes. TFs also have important roles
in the adult life in maintaining the pattern of differentiated
gene expression and several of them function inmultisubunit
protein complexes [1]. Rybp (Ring1 and Yy1 Binding Protein,
also known as Dedaf (Death Effector Domain-Associated
Factor), Yeaf1 (Yy1 and E4tf1 Associated Factor 1); UniGene
Mm.321633; MGI:1929059) is an evolutionarily conserved
TF. It is also a member of the noncanonical mammalian
polycomb repressive complex 1 (PRC1) [2, 3]. PRCs are
important regulators of organogenesis and cell lineage speci-
fication because they are able to maintain pluripotency and
repress differentiation. Rybp also acts as a bridging factor
between E2f and Yy1 binding sites on target gene promoters,
thus facilitating the formation of different multimeric TF
complexes [4]. Complexes that form through these binding
sites play important role in regulating cell proliferation and
differentiation ofmultiple tissue lineages during early embry-
onic development. Rybp is also part of the BCOR complex
(named after its BCL-6 corepressor subunit) [5], which plays
important role in the differentiation of embryonic stem cells
(ESCs) into ectoderm andmesoderm [6] and also is required
for neurogenesis [7].
Our laboratory previously showed that Rybp is essential
for early embryonic development, upregulated in certain cell
types of the developing central nervous system (CNS), and
that in a portion of the 푟푦푏푝+/− mice alterations in Rybp
dosage resulted in striking neural tube defects (NTDs) and
disorganization of the neocortex in vivo [8].
Here, we further characterized the role of Rybp in neural
development. We utilized wild type (푟푦푏푝+/+) and rybp null
mutant (푟푦푏푝−/−) ESCs, which lack functional Rybp protein,
and differentiated them in vitro to neural lineages in order
to reveal the function of Rybp in neural differentiation.
Based on the in vivo evidences we hypothesized that in the
absence of Rybp ESCs cannot undergo neural differentiation
or have impaired neural differentiation ability. We showed
impairment in neural lineage entry of ESCs in the lack
of functional Rybp during in vitro neural differentiation.
When analyzed in depth, the tumor suppressor Plagl1 (Pleo-
morphic Adenoma Gene-like 1 also known as Zac1 (Zinc
Finger Protein Regulating Apoptosis and Cell-cycle Arrest)
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and Lot1 (Lost on Transformation 1) UniGene Mm.287857;
MGI:1100874) was one of the most downregulated genes in
the Rybp deficient cells. Since Plagl1 is a critical regulator of
neural differentiation [9, 10] our results suggest that Plagl1
may, at least partially, mediate the effects of Rybp during
neural differentiation.
2. Materials and Methods
2.1. Chemicals. All chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA), and culture media reagents
were purchased from Invitrogen Life Technologies (Carlsbad,
CA, USA), unless stated otherwise.
2.2. Cell Lines and Culture Condition. Mouse (129SV/Ola) R1
[11] (hereafter mentioned as rybp+/+, control, or wild type)
and D11 [8] (hereafter mentioned as 푟푦푏푝−/− or null mutant)
(Figure S1 in Supplementary Material available online at
http://dx.doi.org/10.1155/2015/4034620) ESCs were thawed
on mitomycin C inactivated mouse embryonic fibroblast
(MEF) layer and cultured on gelatin coated tissue cul-
ture plates as described [12]. The cells were maintained in
ES medium: Dulbecco’s Modified Eagle’s medium (DMEM
(1x) + GlutaMAX-I Dulbecco’s Modified Eagle Medium,
Gibco, REF 31966-021) contained 15% (vol/vol) fetal bovine
serum (Gemini Stasis Stem Cell Qualified FBS, West Sacra-
mento, CA, USA, Cat. Number 100-125), 0.1mM nonessen-
tial amino acids (MEM Nonessential Amino Acids (100x),
PAA, Cat. Number M11-003), 0.1mM 훽-mercaptoethanol
(2-Mercaptoethanol, Gibco, REF 31350-010), 50U/mL peni-
cillin/streptomycin (Penicillin/Streptomycin (100x), PAA,
Cat. Number P11-010), and 1000U/mL Leukemia Inhibitory
Factor (LIF, ESGRO, Chemicon/Millipore, Billerica, MA,
USA). The cells were passaged prior to reaching 70% con-
fluency (approximately every 1-2 days). ESCs were cultured
on gelatin coated dishes for at least two passages prior
to differentiation to deplete potentially present MEF cells
from the ESC culture. Cells were cultured in a humidified
atmosphere containing 5% CO2 at 37∘C. ES medium was
changed daily.
2.3. Induction of Neural Differentiation by Retinoic Acid.
ESCs were induced to differentiate into neuronal lineages as
previously described, with some modifications (Figure 1(a))
[13]. In brief, mouse ESCs were harvested as single cell
suspension using 0.05% (wt/vol) trypsin (Trypsin-EDTA (1x)
0.05%/0.02% in D-PBS, PAA, Cat. Number L15-004) and
then seeded at a density of 4.5 × 105 cells/mL in ES medium
without LIF into 100mm2 bacteriological dishes where cell
attachment was prevented. ESCs were allowed to aggregate
in suspension and form embryoid bodies (EBs) for 8 days.
Medium was changed on every second day during differenti-
ation unless stated otherwise. On the 4th day of EB formation
5 휇M all-trans retinoic acid (RA) (retinoic acid, Sigma, Cat.
Number R2625-100MG) was added to the medium and EBs
were cultured for a further 4 days in the presence of RA.
Thereafter, 8-day-old EBs were dissociated using trypsin
and plated onto poly-L-ornithine (Poly-L-Ornithine 0.01%,
Sigma, Cat. Number P4957) and laminin (Laminin from
Engelbreth-Holm-Swarm murine sarcoma basement mem-
brane, Sigma, Cat. Number L2020-1MG) coated dishes at a
density of 3 × 105 cells/cm2 in DMEM/F-12medium contain-
ing 3mg/mLofD-(+)-glucose, 3mg/mLAlbuMax I, 50U/mL
penicillin/streptomycin, and 1% (vol/vol) N-2 supplement
(N-2 Supplement (100x), Gibco, Cat. Number 17502-048),
and 10 ng/mL recombinant human bFGF (Fibroblast Growth
Factor Basic, human, Sigma, Cat. Number F0291-25UG); the
mediumwas changed 24 hours later. Two days after cells were
plated, the medium was changed to DMEM/F12:Neuronal
Base Medium (Neuronal Base Medium For Neuronal Cells,
PAA, Cat. NumberU15-023) (1 : 1), 1mMGlutaMax, 3mg/mL
AlbuMax I, 50U/mL penicillin/streptomycin, 0.5% (vol/vol)
N-2 Supplement, and 1% (vol/vol) B-27 supplement (B-27
Supplement (50x), Gibco, Cat. Number 17504-044).The cells
were harvested for further analyses on different time points
of neural differentiation: days 0, 3, 7, 10, and 14 (labeled as d0,
d3, d7, d10, and d14). On d10 and d14 the differentiated cells
were also stained with cresyl violet in order to visualize the
cell colonies and morphology of the cells. The images of the
ESC cultures, EBs, and stained neural culture were obtained
using Olympus cellR microscope (Olympus Corporation,
Japan).
2.4. Quantitative Real-Time PCR (qRT-PCR). For quanti-
tation of mRNA levels during the in vitro differentiation
quantitative real-time PCR (qRT-PCR) assays were per-
formed. Total RNA was extracted from the harvested cells
using Qiagen RNeasy Plus Mini Kit (Qiagen, Cat. Number
74134 Hilden, Germany) according to the manufacturer’s
instructions. cDNA synthesis was achieved with the isolated
RNA using Applied Biosystems High capacity cDNA Reverse
TranscriptionKit (InvitrogenLife Technologies, Cat.Number
4368814Carlsbad, CA, USA) according to themanufacturer’s
instructions.
qRT-PCR was performed in SYBR Green master mix
(SYBR Select Master Mix for CFX, Applied Biosystems,
REF 4472942) using Bioer LineGeneK Real-time PCR Sys-
tem (Bioer, China). Relative gene expression changes were
quantified using the ΔΔCt method. The threshold cycle (Ct)
values for each gene were normalized to expression level of
Hprt, as internal control. To calculate fold change, the values
were compared to undifferentiated samples (d0, 푟푦푏푝+/+).
The primers used in this study were listed in Supplementary
Table 1.
2.5. Immunocytochemistry Analysis. For immunofluorescence
staining of the cells, they were plated onto coverslips, differ-
entiated into neuronal lineages as described above, and fixed
with 4% (v/v) paraformaldehyde (PFA) for 20min at room
temperature (RT). After permeabilization in 0.2% Triton
X-100 (Triton X-100, Sigma, Cat. Number T8787-250ML)
in Phosphate Buffered Saline (PBS, DPBS (1x) Dulbecco’s
Phosphate Buffered Saline, Gibco, REF 14190-094) for 20min
at RT, cells were blocked in 5% Bovine Serum Albumin
(BSA) (Albumin from bovine serum, Sigma, Cat. Number A-
7906) in PBS for 1 h at RT and then sequentially incubated
with the following primary antibody in 5% BSA overnight at
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Figure 1: Morphological changes of 푟푦푏푝+/+ and 푟푦푏푝−/− cells through in vitro neural differentiation. (a) Schematic illustration of in vitro
neural differentiation as described previously by Bibel et al. (b) The 푟푦푏푝−/− ESCs display the same morphology in culture as the wild type
(d0) and also form EBs (d3, d7).There is no noticeable difference between the two cell lines. After the plating (d10, d14) the 푟푦푏푝−/− cells grew
less organized neural network than the wild type. Magnifications are 4x (d3, d7) and 10x (d0, d10, d14). Scale bars represent 500 휇m (d3, d7)
and 200 휇m (d0, d10, d14).
4∘C: Nestin (Rat-401, Hybridoma Bank, Iowa, USA, 1 : 100),
Pax6 (Pax6, Hybridoma Bank, Iowa, USA, 1 : 100), Tuj1
(Neuronal Class III 훽-Tubulin Polyclonal Antibody; Cov-
ance, Cat. Number PRB-435P, 1 : 2500), Gfap (Monoclonal
Anti-Glial Fibrillary Acidic Protein Clone G-A-5, Sigma,
Cat. Number G3893, 1 : 400), and Plagl1 (Zac1 (M-300),
Santa Cruz Biotechnology, Cat. Number sc-22812, 1 : 1000).
The cells were washed 5 times with PBS and incubated
with fluorescent-labeled secondary antibodies (Alexa Fluor
647 Donkey-Anti-Mouse, Invitrogen, Cat. Number A-31571;
Alexa Fluor 647 Goat-Anti-Rabbit, Invitrogen, Cat. Number
A-21244; Alexa Fluor 488 Goat-Anti-Mouse, Invitrogen, Cat.
Number A-10667) for 1 h at RT. Then the cells were washed
3 times with PBS. The cells were rinsed in 4耠,6-diamidino-
2-phenylindole (DAPI; Vector Laboratories, Cat. Number H-
1200) for 20min, washed 2 times with PBS, and mounted in
50% glycerol.The images were obtained using Olympus LSM
confocal microscope (Olympus Corporation, Japan).
2.6. Statistical Analysis. All experiments were repeated three
times. Experiments were evaluated with SPSS/PC+ version 17
program (SPSS, Chicago, IL) by using 푡-test type 3. Means
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are standard deviation. Values of 푃 < 0.05 were accepted as
significant (∗푃 < 0.05; ∗∗푃 < 0.01; ∗∗∗푃 < 0.001).
3. Results
3.1. Neural Cell Culture Differentiated from 푟푦푏푝−/− ESCs
Exhibit Different Morphology than Wild Type. In order to
investigate the possible molecular mechanisms underlying
the in vivo neural phenotypes of the 푟푦푏푝+/− mice we took
advantage of the ESC based in vitro neural differentiation
system. Thus, we adopted the protocol by Bibel et al. [13]
in order to differentiate 푟푦푏푝+/+ [11] and 푟푦푏푝−/− [8] ESCs
lacking functional Rybp protein product towards neural
cell lineages (Figure 1(a)). In brief, suspension cultures were
initiated using 4.5 × 105 cells/mL initial seeding density and
were kept in suspension for 8 days to form EBs. RA was
added to the suspension cultures on d4 and EBs were kept
in RA supplemented medium until trypsinization on d8
and then seeded on poly-L-ornithine/laminin coated surfaces
and differentiated further for another week. Samples for
analysis were taken at d0, d3, d7, d10, and d14 and processed
as required. 푅푦푏푝−/− ESCs display similar morphology in
culture as the control cell line (Figure 1(b) d0) and by d7 EBs
grew larger compared to d3 in both cell lines (Figure 1(b),
d3, d7) suggesting that 푟푦푏푝−/− cells are not compromised in
their ability to form EBs and proliferate. As expected, after
plating EBs on poly-L-ornithine and laminin coated surfaces,
the wild type cells exhibited typical neuronal morphology
and the cells grew axon-like outgrowth, connected to each
other, and organized in a complex network consisting of
heterogeneous cell population (Figure 1(b) d10, d14). How-
ever, 푟푦푏푝−/− cells grew less neurite processes and their
organization into network was less extended in comparison
to the wild type. This phenotype was independent from the
initial cell density (Figure 1(b), d10, d14; data not shown).
The gross morphology of the cells suggests that neuronal
differentiation was affected by absence of rybp.
3.2. Expression of Pluripotency Markers in the Lack of Rybp
during Neural Differentiation. To uncover underlyingmRNA
expression changes during in vitro neural differentiation
we evaluated gene expression levels by qRT-PCR. First, we
confirmed that the 푟푦푏푝−/− cells do not produce functional
protein (Figure 2(a)). Then we analyzed the expression of
pluripotency markers in both cell lines. Incomplete silencing
of the pluripotency genes during differentiation inhibits neu-
ral differentiation. The analysis revealed that the expression
of examined pluripotency markers Oct4 and Nanog was pro-
gressively downregulated in both cell lines by differentiation
(Figures 2(b) and 2(c)) and there were no significant changes
in the kinetics of pluripotency gene expression between the푟푦푏푝+/+ and 푟푦푏푝−/− cells.
Sox2 together with Oct4 and Nanog maintains pluripo-
tency in stem cells and neural progenitors (NPCs) and,
in addition, Sox2 is also important in the induction of
neuroectoderm [14, 15]. The relative expression levels of
Sox2 in both cell lines are similar with the exception of
d14 when the level of Sox2 is diminished in the rybp null
mutant whilst it stays high in the wild type (Figure 2(d)).This
suggests that the differentiation ability of rybp null stem cells
to NPCs or maintaining the characteristics of NPCs might
be compromised. These results suggested that the silencing
of key pluripotency genes exhibits similar kinetics with the
exception of Sox2, which in the rybp nullmutants drastically
declines by d14.
3.3. Expression of Key Neural Markers in the Lack of Rybp
during Neural Differentiation. After examination of the key
pluripotency markers we analyzed the relative gene expres-
sion of key neural markers (e.g., Nestin, Pax6, NeuroD1,
Tubb3, NeuN, Gfap, and Olig2) in both cell lines to gain
information about the kinetics of neural differentiation.
Nestin is a widely employedmarker ofmultipotent neural
stem cells (NSCs) [16]. Once the cells become differentiated,
Nestin expression is downregulated both in vivo and in vitro
[17]. As expected, at the time of neural induction (d7, RA
treatment) Nestin is strongly upregulated at d7 in both cell
lines (Figure 3(a)). Nestin expression increased further after
plating of the cells (d10) and its level decreased only at
later phases of neural differentiation (d14) in both cell lines
(Figure 3(a)). Notably, Nestin expression was more robust
in the 푟푦푏푝−/− cell line compared to the 푟푦푏푝+/+ at d10.
Immunocytochemistry with Nestin antibody confirmed the
presence of NPCs in both cell lines with stronger expression
in the 푟푦푏푝−/− cells at d10 (Figure 4(a)). By the endpoint of
in vitro neural differentiation (d14) the number of Nestin
expressing cells was reduced in both cell lines (Figure 4(a);
Figure S2(a) and (b)). These results suggest that early neural
processes take place in a greater extent in the absence of
functional Rybp.
Paired Box 6 (Pax6) gene is required for the initiation of
neural differentiation and described as an essential factor for
normal eye development aswell [18]. Relative gene expression
analysis revealed that Pax6 is upregulated after the RA
treatment (Figure 3(b) fromd7) and its level decreased at later
time points of neural differentiation (d14) in the wild type
cells. Expression of Pax6 was higher after neuroectodermal
induction in the 푟푦푏푝−/− cells compared to the wild type
(Figure 3(b) from d7). Pax6 immunostaining visualizes the
distribution of Pax6 positive cells in the wild type and
mutant neural cell cultures (Figure 4(b)). The Pax6 signal
was stronger in the mutant cultures in all examined time
points (Figure 4(b); Figure S2(c) and (d)). In both cell lines
the number of Pax6 positive cells is higher at d10 when early
differentiation events take place. These results correlate with
the data of Pax6 qRT-PCRanalysis and indicate an abundance
of Pax6 positive cell population in the rybp nullmutants.
Neurogenic Differentiation 1 (NeuroD1) is a TF, which
is essential for terminal neuronal commitment of maturing
neurons [19]. NeuroD1 drives premature differentiation of
neuronal precursors into mature neurons. Relative gene
expression analysis by qRT-PCR showed that the NeuroD1 is
mildly expressed after RA treatment (d7) in both cell lines
(Figure 3(c)).The expression level of NeuroD1 is significantly
higher at early stage (d10) in the mutant cell line compared
to the wild type. The expression of NeuroD1 decreased by
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Figure 2: In the lack of Rybp there is no change in silencing of key pluripotencymarkers (Oct4, Nanog) during in vitro neural differentiation.
Relative gene expressions of Rybp (a), Oct4 (b), Nanog (c), and Sox2 (d) were analyzed by qRT-PCR. For the analysis RNA was extracted and
reverse-transcribed from differentiated neural cell culture generated from 푟푦푏푝+/+ and 푟푦푏푝−/− ESCs. Samples are collected at days 0, 3, 7, 10,
and 14 of differentiation.The expression of the indicated markers was normalized to Hprt expression, which was used as an internal control.
Means are standard deviation. Values of 푃 < 0.05 were accepted as significant (∗푃 < 0.05; ∗∗푃 < 0.01; ∗∗∗푃 < 0.001). Statistical method: 푡
test type 3.
the end of differentiation (d14) in the 푟푦푏푝−/− cells whilst
there is only a minor decrease in its level in the 푟푦푏푝+/+
cells. At d14, NeuroD1 expression is higher in the wild type
cells compared to the mutants. This also confirms that the
characteristics of NPCs are altered in the rybp null mutants:
at the beginning/mid-phase of differentiation (d7 and 10) the
premature differentiation of NPCs is accelerated but by the
end of differentiation (d14) it is attenuated.
Class III Beta-Tubulin (Tubb3) plays a critical role in
proper axon guidance, maintenance, and axonal transport
[20, 21] and also is expressed in postmitotic phase of dif-
ferentiating neurons [22]. Relative gene expression analysis
by qRT-PCR showed that Tubb3 expression is elevated at
early stage (d10) in both cell lines but its expression declines
in the 푟푦푏푝−/− cells at later stage of neural differentiation
(d14) while its level still remains high in the wild type
(Figure 3(d)). In order to visualize ongoing neural differ-
entiation spatiotemporally we stained the cells with Tuj1
antibody,whichmarksTubb3positive cells.The assessment of
Tuj1 staining (Figure 4(c); Figure S2(e) and (f)) showed that
neurite processes and axon-like structures start to develop
in both cell lines however in the 푟푦푏푝+/+ cells exhibit a
complex and dense network of outgrowth compared to the
mutants. Notably, Tubb3 also is expressed in the soma,
around the nucleus in 푟푦푏푝+/+ cells, while in the 푟푦푏푝−/−
cells this staining was less visible. The reduced density of
nerve fibers by ICC in the mutant cell line was consistent
with the data on diminished amount of nerve bundles on
Tubb3 by qRT-PCRanalyses.These data suggest that a normal
level of Rybp is important for the proper development of
neurons.
In order to ascertain the presence of mature neurons
in our cell cultures we assessed the relative gene expression
changes of postmitotic neuronal marker NeuN (also known
as Rbfox3). NeuNmarks the nuclei of maturing and differen-
tiated neurons [23]. As expected, qRT-PCR analysis showed
that NeuN was abundantly expressed in the plated wild type
neural cultures (d10, d14) but its level stayed constantly low
in the mutants (Figure 3(e)). This indicates that much less
mature neurons formed in the rybp null mutant culture (d10,
d14) and further confirms the compromised differentiation
ability of rybp null NPCs.
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Figure 3: Neural markers (Nestin (a), Pax6 (b), NeuroD1 (c), Tubb3 (d), NeuN (e), Gfap (f), and Olig2 (g)) and transcription factor, Plagl1
(h), exhibit altered expression in the lack of Rybp during in vitro neural differentiation. Relative gene expression of key neural markers was
analyzed with qRT-PCR. For the analysis RNA was extracted and reverse-transcribed from differentiated neural cell culture generated from푟푦푏푝+/+ and 푟푦푏푝−/− ESCs. Samples are collected at days 0, 3, 7, 10, and 14 of differentiation. The expressions of the indicated markers were
normalized to Hprt expression, which was used as an internal control. Means are standard deviation. Values of 푃 < 0.05 were accepted as
significant (∗푃 < 0.05; ∗∗푃 < 0.01; ∗∗∗푃 < 0.001). Statistical method: 푡 test type 3.
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Figure 4: Continued.
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Figure 4: Rybp deficient cells show impaired protein expression of neural markers during in vitro neural differentiation. Immunocytochem-
ical analysis of in vitro differentiated neural cultures shows that there are more Nestin (a) and Pax6 (b) and less Tuj1 (c) are visible in the rybp
null mutant neural cell cultures by d10. Nestin and Tuj1 staining are reduced in the 푟푦푏푝−/− cell culture by d14 compared to wild type, which
indicates possible defects in the late neural processes. Immunostaining of astrocyte marker, Gfap (d), shows a small amount of astrocyte-like
cells in wild type culture, which is absent in themutant. Immunocytochemistry with antibody against Plagl1 (e) reveals that Plagl1 is expressed
in the nucleus of 푟푦푏푝+/+ cells but it is absent in 푟푦푏푝−/− cells. Magnification is 60x. Scale bars represent 60 휇m.
This observation tempted us to speculate whether this
defect is specific for neurons or other cell types like astrocytes
and oligodendrocytes are also affected in the absence of Rybp.
Therefore we next analyzed whether cells lacking functional
Rybp are able to generate astrocytes as well. In order to do
so, we have performed relative gene expression analysis by
qRT-PCR in both cell lines for the intermediate filament
Glial Fibrillary Acidic Protein (Gfap), which is a commonly
accepted marker of radial glia and astrocytes [24]. Our
analysis revealed that the level of Gfap is elevated over ∼
300x in the wild type cells (Figure 3(f) d14). In comparison
its level stayed low in the rybp null mutants (Figure 3(f)
d14). We also analyzed the spatial distribution of Gfap by
immunostaining and found that there were no Gfap positive
cells in the mutant neural cultures (Figure 4(d); Figure S2(g)
and (h)). This suggests that the astrocyte differentiation is
defective in the mutant cells.
We also investigated if the absence of Rybp has influence
on other types of glial cells or it is specific for astrocytes.
For this purpose, we measured the relative expression level
of Oligodendrocyte Lineage Transcription Factor 2 (Olig2)
by qRT-PCR. Olig2 is a marker gene for oligodendrocytes
[25–27]. Oligodendrocyte differentiation normally starts by
d7 and peaks by d14 (Figure 3(g) 푟푦푏푝+/+ cells). In contrast,
the 푟푦푏푝−/− cells expressed 60x less Olig2 mRNAs at d14
compared to the wild type (Figure 3(g)). This demonstrates
that oligodendrocyte differentiation is also impaired in the
absence of Rybp.
3.4. Plagl1 Is aDownstreamTarget of Rybp during InVitroNeu-
ral Differentiation. Previously, we have shown that Plagl1 is a
candidate downstream gene of Rybp during in vitro cardiac
differentiation of mouse embryonic stem cells [28]. Plagl1 has
dual role; it is an important gene for cardiac development
and it has also crucial role in neural development [10, 29].
Moreover, lack of Plagl1 in mouse models caused marked
defects in CNS development (e.g., reduced size of cerebellum,
reduced number of mature neurons) [9], which are similar to
the phenotype of the 푟푦푏푝+/− mice (see above, Section 1) [8].
Therefore, next we have tested whether the differences
in mRNA expression are also sustained (or changed) during
neural differentiation between the wild type and rybp null
mutant cell lines. Gene expression analysis (Figure 3(h))
revealed that Plagl1 is strongly induced (∼300x) after the
RA treatment (d7) during in vitro neural differentiation in
the wild type cells and remained high until the end of
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differentiation (d14). However in the 푟푦푏푝−/− cells Plagl1 was
not induced and showed complete deficiency.
After this, we wanted to test whether the difference in
Plagl1 mRNA induction is also sustained at protein level.
In order to visualize the spatiotemporal distribution of
Plagl1 throughout the differentiation process we performed
immunocytochemistry of in vitro neural cultures with anti-
body against the Plagl1 protein (Figure 4(e); Figure S2(i) and
(j)). This confirmed that Plagl1 is visible in the nuclei of
the wild type cells (Figure 4(e), wild type cells at d10 and
d14) while in the 푟푦푏푝−/− cells there is a complete lack of
Plagl1 staining. These results showed that Plagl1 induction is
impaired in 푟푦푏푝−/− cells during the entire course of neural
differentiation.
4. Discussion
Current work investigates the possible underlying molecular
mechanisms responsible for the previously described pheno-
type of the rybp heterozygous mouse models [8]. Consid-
erable attention has focused on the search for downstream
target genes that may mediate the biological effect of Rybp
in neural lineage commitment. Our study showed that the
development of both neuronal and glial lineages is defective
in the rybp null ESCs derivatives. Furthermore, our study
establishes that the process of differentiation towards mature
neural cell types rather than to a specific lineage is impaired
in the lack of Rybp.
The contribution of 푟푦푏푝−/− ESCs to neural lineage
commitment is particularly interesting since in vivo evidence
has been already provided that Rybp is important for neural
development and it is broadly expressed in different cell types
of the CNS. Moreover misexpression of Rybp was shown in
glioblastomas and other types of tumors [30].
Our results showed that the properties of rybp null NPCs
are compromised: rybp null NPCs express Pax6, Nestin,
and NeuroD1 in excess in comparison to the wild type
ones. Pax6 is one of the key transcriptional factors [31],
whose level needs to be upregulated at the beginning of
neural development since Pax6 plays important role in
establishing neuronal progenitor pool during the vertebrate
nervous system development [32] (Figure 5). At the same
time downregulation of Pax6 is also necessary for the
forthcoming, late neural differentiation. In our assays when
Rybp is absent, Pax6 is upregulated. Since high level of
Pax6 obstructs terminal differentiation of NPCs it is possible
that this elevated level of Pax6 helps to keep NPCs at the
early stage of differentiation and inhibits the forthcoming
late neural processes in the 푟푦푏푝−/− cells [33] (Figure 5).
Upregulation of Nestin and NeuroD1 also confirms that
early neural processes are accelerated in the lack of Rybp
compared to the wild type. At the same time, silencing of key
pluripotency genes (e.g., Oct4, Nanog) is a well coordinated
event in the absence of Rybp indicating that improper
silencing of pluripotency genes cannot be the causative of
the phenotype. The only exception is Sox2 since the pool
of Sox2 positive cells is reduced in the rybp null mutants
earlier than in the wild type neural cultures. Sox2 is not only
a critical factor for maintaining pluripotency and directing
the differentiation of stem cells to neural progenitors but it is
also important for maintaining the properties of NPCs [15].
Downregulation of Sox2 resulted in progenitor cells losing
capability to both proliferate and terminally differentiate
[34]; however to determine how Sox2 dose-change alters the
state of NPCs in neural differentiation is a debate of future
studies. Since others already described that striking increase
of Pax6 partially rescues the Sox2 mutant phenotype [35],
it cannot be excluded that increased level of Pax6 in the
null mutant compensates the effect of low level of Sox2. It is
possible that the lack of Rybp alters the balance amongmajor
transcription factors governing the NPC pool generation and
consequent differentiation events. Changing the expression
level of one or more members in these circuits will shift the
finely tuned balance and initiate premature differentiation.
Alternatively, this suboptimal balance may exhaust the NPC
pool, which obscures consequent differentiation events, since
Rybp is a moonlighting protein and is involved in such
diverse biological functions as ubiquitination [3], apoptosis
[36], and transcriptional repression [4], and it may have
multiple roles in regulating neural differentiation as well. It
further complicates the situation that Yaf2 (the othermember
of the Rybp/Yaf2 gene family) may compensate for the lack of
Rybp at certain extent [37, 38].
Decreased level of late neuronal markers (Tuj1, NeuN,
Gfap, and Olig2) indicates that maturing of neurons, oligo-
dendrocytes, and astrocytes are deficient in the rybp null
mutant cells (Figure 5). Parallel with these, the mutant cells
seem to form a larger NPC pool (d10) and less astrocytes
and oligodendrocytes in comparison to the wild types (d14).
Overall, these observations confirm that maturation of neu-
rons, astrocytes, and oligodendrocytes are deficient in the
rybp null mutant cells and this process is not lineage specific.
The other gene whose expression is drastically changed in
the 푟푦푏푝−/− neural cultures is Plagl1, which is an important
regulator of neural development, apoptosis, and cell-cycle
arrest whereas it has antiproliferative activity [39, 40]. Plagl1
is normally expressed in the progenitor cells of ventricular
zone, subventricular zone, and external granular cell layer
of the brain and promotes cell-cycle withdrawal of NPCs
during the differentiation processes [10].The tight regulation
of cell-cycle processes is required to ensure timely generation
and correct amount of the various neural cell types, which
largely depends on the presence of Plagl1. The observation
that Plagl1 is almost completely downregulated in the absence
of functional Rybp and the fact that Rybp and Plagl1 deficient
mice exhibit similar development defects (reduced number
of mature neurons, reduced size of cerebellum, etc.) indicate
a possible genetical or biochemical link between Rybp and
Plagl1 [8, 9]. In our study increased level of Pax6 is accompa-
nied by the downregulation of Plagl1 in Rybp deficient cells.
In the absence of functional Rybp it is very likely that the
balance of early and late neural processes is “unbalanced,”
which is probably linked to the upregulation of Pax6 and/or
the loss of Plagl1 (Figure 5).
Possibilities for action of Rybp are likely very diverse.
Recent studies showed that Rybp is a member of the recently
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Figure 5: Model of in vitro neural differentiation in ESCs in presence and absence of Rybp. (a) Differentiation of wild type ESCs towards
matured cell types of the CNS in the presence of Rybp. Pluripotent ESCs express key pluripotency markers (e.g., Oct4, Nanog) in
undifferentiated state, which are gradually decreasing through in vitro neural differentiation. Parallel with this, early neural markers (Pax6,
Nestin) are upregulated in NSCs, which will confer reduced proliferative and high differentiation capacity to the cells. On the other hand, in
the presence of Rybp, upregulation of Plagl1 helps to facilitate late neural differentiation and inhibits cell proliferation, which will facilitate the
generation of terminally differentiated neural cell types (N, OC, and AC). By the progression of neural differentiation, NPCs will differentiate
further and start to express markers of specialized neural cell types (Tuj1, NeuN, Olig2, and Gfap). (b) Differentiation of pluripotent ESCs
towards matured cell types of the CNS is impaired in the absence of Rybp. During neural differentiation early neural markers (Pax6, Nestin)
exhibit elevated expression level in the rybp nullmutants.These will facilitate the generation of a bigger pool of NPCs with higher proliferative
capacity. On the other hand, in the absence of Rybp, Plagl1 expression is defective, which also contributes to increased proliferative and
decreased differentiation capacity of the NPCs. As a result, the formation of terminally differentiated neural cell types (N, OC, and AC) will
be impaired in the lack of functional Rybp. ESC: embryonic stem cell; NSC: neural stem cell; NPC: neural progenitor cell; N: neuron; OC:
oligodendrocyte; AC: astrocyte; RA: retinoic acid; CNS: central nervous system.
identified noncanonical PRC1 complex with unknown bio-
logical functions [41]. This complex is also encompassing
Kdm2b, a gene with essential function during embryonic
development. Notably, loss of Kdm2b is perinatally lethal
with incomplete neural tube closure, exencephaly, and altered
cell-cycle processes in NPCs [42] mimicking the phenotype
of the rybp heterozygous mice [8]. Kdm2b, like Rybp, is also
the member of the BCOR complex [5], which also plays
important role in neurogenesis suggesting further possible
functional cooperation between the two genes [7]. Impor-
tantly,members of the PRCs are proven to play important role
in neural development: loss of Ring1B, which is core member
of the canonical PRC1 and binding partner of Rybp, causes
premature neuronal differentiation [43]. Ezh2, a coremember
of the PRC2, is highly expressed in NPCs and downregulated
through the differentiation of mature cortical neurons [44].
Notably, Neurogenin 1, has been found to be suppressed by
a PRC mediated mechanism at the neuronal-to-astrocytic
transition of NPC differentiation during corticogenesis [45].
To clarify whether Rybp is functioning as the member of
PRCs or other multimeric protein complexes during neural
development is a debate of future studies.
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Lack of Rybp in Mouse Embryonic Stem Cells
Impairs Cardiac Differentiation
Olga Ujhelly,1 Viktoria Szabo,2 Gergo Kovacs,2 Flora Vajda,2 Sylvia Mallok,3 Janos Prorok,4
Karoly Acsai,5 Zoltan Hegedus,6 Stefan Krebs,3 Andras Dinnyes,1,7 and Melinda Katalin Pirity2
Ring1 and Yy1 binding protein (Rybp) has been implicated in transcriptional regulation, apoptotic signaling and
as a member of the polycomb repressive complex 1, it has an important function in regulating pluripotency and
differentiation of embryonic stem cells (ESCs). Earlier, we had proved that Rybp plays an essential role in
mouse embryonic and central nervous system development. This work identifies Rybp, as a critical regulator of
heart development. Rybp is readily detectable in the developing mouse heart from day 8.5 of embryonic
development. Prominent Rybp expression persists during all embryonic stages, and Rybp marks differentiated
cell types of the heart. By utilizing rybp null ESCs in an in vitro cardiac differentiation assay, we found that
rybp null ESCs do not form rhythmically beating cardiomyocytes (CMCs). Gene expression profiles revealed a
downregulation of cardiac terminal and upregulation of germline-specific markers in the rybp null CMCs.
Furthermore, transcriptome analysis uncovered a number of novel candidate target genes regulated by Rybp.
Among these are several that are important in cardiac development and contractility such as Plagl1, Isl1, and
Tnnt2. Importantly, forced expression of rybp in rybp-deficient ESCs by a lentiviral vector was able to rescue
the mutant phenotype. Our data provide evidence for a previously unrecognized function of Rybp in heart
development and point out the importance of germ cell lineage gene silencing during somatic differentiation.
Introduction
Acomplex network of transcription factors governs thespatiotemporal patterns of gene expression in the organs
of the developing embryo proper. Transcription factors also
have important roles in postnatal and adult life in maintaining
the pattern of differentiated gene expression [1–3]. Ring1 and
Yy1 binding protein [Rybp, also known as Dedaf (Death
Effector Domain-Associated Factor), UniGene Mm.321633;
MGI:1929059] is a repressor protein that is also a member of
the mammalian polycomb repressive complex 1 (PRC1) [4].
First, Rybp was described as a binding partner for the poly-
comb group protein (PcG) Ring1A (Ring1; ortholog of
Drosophila dRing/Sce) and was also shown to associate with
Ring1B (Ring2/Rnf2; ortholog ofDrosophila dRing/Sce) and
M33 (Pc1; ortholog of Drosophila Pc), components of the
PRC1 multiprotein complex [5].
Our previous work showed that Rybp is selectively up-
regulated in distinct structures and cell types of the devel-
oping eye and the central nervous system (CNS), and it may
also play a role in the development of more mature neurons
[6,7]. We have also shown that rybp is essential for the
development of the mouse embryo proper and that homo-
zygous null mouse embryos cannot develop further im-
plantation [embryonic day 5.5 (E5.5)]. Notably, in a subset
of heterozygous animals and in rybp-/-4rybp+/ + chime-
ras, alterations in Rybp dosage induced striking neural tube
defects (NTDs) [6,7]. These findings have demonstrated the
integral role of Rybp at the early postimplantation and later-
stage CNS development. Simultaneously, early embryonic
lethality of the rybp homozygous null embryos were ob-
stacles to the study of the precise role of Rybp at later
developmental stages or the development of other organs.
In this study, the early lethal effect of Rybp deficiency
was overcome by utilizing rybp-/- embryonic stem cells
(ESCs) to model cardiac differentiation in the lack of Rybp.
Our results showed that ESCs lacking functional Rybp are
not able to form contractile cardiomyocytes (CMCs) and
that Rybp is important for the proper expression of several
key regulators of cardiac development. Recent data provide
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the first evidence that Rybp is required for the formation of
beating CMCs. This defines a novel role for Rybp in
mammalian heart formation and has implications for the
understanding of heart diseases.
Materials and Methods
Experimental procedures
All chemicals were purchased from Sigma-Aldrich and
all the culture reagents were from Invitrogen Life Tech-
nologies, unless otherwise specified.
Cell culture
Mouse R1 [8] [hereafter mentioned as rybp+/+ or wild-
type (WT) ESCs] and rybp null [6] (hereafter mentioned as
rybp-/- ) ESCs were thawed on mitomycin C (MitC; Sigma-
Aldrich) inactivated mouse embryonic fibroblast (MEF)
layer and cultured on gelatin-coated tissue culture plates as
described [9]. All cells were cultured at 37!C in a humidi-
fied atmosphere containing 5% CO2. ESCs were cultured in
ESC medium, consisting of Dulbecco’s modified Eagle’s
medium GlutaMaxI, 15% (v/v) ES cell qualified fetal calf
serum (SLI Ltd.), 1% (v/v) nonessential amino acids, 1%
(v/v) Pen/Strep, 100mM 2-mercaptoethanol, and 1,000U/mL
1eukemia inhibitory factor (LIF, ESGRO; Chemicon/Milli-
pore). Medium was changed daily on mouse ESC cultures
and every 2 days during differentiation.
Expression vectors
To generate Rybp/Egfp expression constructs, we modi-
fied the original vector of Lois et al. to include a multiple
cloning site and an IRES sequence upstream of the Egfp
gene [10]. We cloned the Rybp cDNA to the multiple
cloning site by the Xba1/Nhe1 digest. We also substituted
the ubiquitin-C promoter by the promoter of the elongation
factor-1a (EF1a) gene.
Production of lentiviruses
All recombinant lentiviruses were produced by transient
transfection of 293T cells, as described byDull et al. [11]. The
packaging constructs were obtained through Addgene (ref
No: pMD2.G: 12259, pRSV-Rev: 12253, pMDLg/pRRE:
12251). The lentiviral particles were tested on 293T cells.
Transduction of ESCs
Lentiviral particles were added to ESCs in expansion
culture medium (MOI: 3–5) in the presence of 8 mg/mL
polybrene andwere centrifuged for 30min on 1,000g at 32!C.
After overnight incubation at 37!C, the full medium was
changed to fresh expansion medium. The cells were assayed
3 days after infection.
Immunoblot analysis of ESCs
Immunoblotting experiments of ESCs were carried out on
50 mg protein from whole cell lysates fractionated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis using
secondary antibodies conjugated with horseradish peroxi-
dase (HRP, AP132P; Millipore). The intensities of the re-
active bands were detected by Bio-Rad Opti-4CN Substrate
Kit (170-8235). Anti-Rybp (anti-Dedaf 1:1,000, AB3637;
Chemicon) was used for the detection of Rybp protein ex-
pression.
Immunocytochemistry
For immunofluorescence staining of the cells, cells were
plated onto 0.1% gelatin-coated coverslips and fixed with
4% paraformaldehyde (PFA) for 15min at room tempera-
ture. Cells were permeabilized with 0.05% Triton-X-100/
phosphate-buffered saline (PBS) for 10min at room tem-
perature, followed by blocking in 1% bovine serum albumin
for 1 h at room temperature. Cells were washed with PBS
and incubated overnight with primary antibody at 4!C.
Primary antibodies used for this study include Oct3/4 anti-
body (C-10, 1:100; Santa Cruz), anti-Rybp (anti-Dedaf
1:1,000, AB3637; Chemicon), and cardiac Troponin T anti-
body [Ms mAb Cardiac Troponin T (1C11) 1:2,000, ab8295;
Abcam]. After washing thrice with PBS, cells were labeled
with Alexa Fluor"647-conjugated secondary antibodies (for
Oct3/4 antibody and for anti-Rybp; Invitrogen) and Alexa
Fluor 488 Goat Anti-Mouse IgG (H +L) secondary antibody
(1:2,000, A11001; Invitrogen) for 1 h at room temperature.
Cells were then washed thrice with PBS and covered with
DAPI mountingmedium (VectaShield; Vector Laboratories).
Imaging was performed with an Olympus Cell" Imaging
microscope (Olympus Corporation) and with an Olympus
LSM confocal microscope (Olympus Corporation). The
captured images of immunocytochemistry (ICC) were semi-
quantified using Olympus FluoView software.
Histology and immunohistochemistry
Embryos and adult mouse testis were collected, washed
thrice in PBS, fixed overnight with 4% PFA, embedded in
paraffin, and examined for general histological analysis.
Serial sections were generated, and 4-mm-thick sections
were hematoxylin and eosin stained for morphology as-
sessment and with anti-Rybp (anti-Dedaf 1:1,000, AB3637;
Chemicon) for monitoring endogenous Rybp staining. The
sections were analyzed and imaged by using a Zeiss Ax-
ioImager Z1 microscope (Carl Zeiss MicroImaging GmbH).
mRNA expression analysis
Total cellular RNA was isolated using the RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions.
The RNA prep was DNase treated (Promega), and tran-
scribed by the Superscript II cDNASynthesis Kit (Invitrogen,
by Life Technologies), as per the manufacturer’s instructions.
Quantitative real-time polymerase chain reaction (RT-PCR)
was performed in the SYBR Green JumpStart Taq ReadyMix
(S4438) for the QPCR green master mix, in the Rotor-Gene Q
real-time PCR machine (Qiagen). Gapdh was used as an in-
ternal control. Experiments were performed in triplicate and
repeated at least twice. See primer sequences in Supple-
mentary Table S1; SupplementaryData are available online at
www.liebertpub.com/scd.
In vitro cardiac differentiation
For cardiac differentiation, embryoid bodies (EBs) were
generated by the hanging-drop (HD) method as previously
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described [12]. For single-cell suspensions, the cells were
dissociated from monolayer culture with 0.25% trypsin-
EDTA [day 0 (d0)]. The cells were counted, and 800 cells/
20 mL differentiation medium (ESC medium without LIF)
were pipetted on the lid of a bacterial Petri-dish. The dish
was filled with PBS to prevent the droplets from drying
out. The cells were allowed to aggregate with the help of
gravity by reversing the Petri-dish lid. On day 2, individual
EBs were plated into a well of a 24-well plate containing
0.1% gelatin-coated coverslips. Differentiation medium was
changed every second day; the number of CMCs was con-
tinuously observed and recorded. The CMCs were further
processed as required (eg, monitoring [Ca2 + ] transient and
cell contraction or mRNA expression analysis) or fixed on
day 7 (d7), day 14 (d14), and day 21 (d21) for ICC.
Quantification of beating activity of EBs
Quantification of beating activity of EBs was performed
as previously described [13,14]. In brief, the number of
spontaneously beating clusters was recorded daily after
plating EBs under a Nikon TMS inverted light microscope
(Nikon Instruments, Inc.). The number of beating EBs was
represented as the percentage of the total plated EBs. The
cardiac beatings were further evaluated by grading of car-
diac beating (area of cardiac beating and beating rate) as
described earlier [13,14]. The results represent the mean –
SEM of three independent experiments. Statistical analyses
for a comparison of the percentage of the EB beating and
the grading of EB beating between groups were conducted
using a one-way ANOVA of SPSS Statistics version 18.0.
Monitoring [Ca2 + ]i transient and cell contraction
CMCs were loaded with 5mM Fluo-4 (Molecular Probes,
Inc.), in DMSO + 20% pluronic acid F-127 (Sigma-Aldrich)
in differentiation medium for 40min in the dark at room
temperature. Subsequently, myocytes were washed twice
with normal Tyrode’s solution and placed on the stage of an
inverted fluorescent microscope (Eclipse TE2000; Nikon).
The Tyrode’s solution contained the following (in mM): 144
NaCl, 0.4 NaH2PO4, 4 KCl, 0.53 MgSO4, 1.8 CaCl2, 5.5
glucose, and 5 HEPES, pH 7.4 with NaOH. Fluo-4 was ex-
cited at 480 nm; fluorescence emission was recorded at
535 nm by using appropriate filter sets (Chroma Technology).
Optical signals were recorded by a photon counting photo-
multiplier module (H7828; Hamamatsu) and sampled at
1 kHz. Cell contraction was determined by a video edge de-
tection system (VED-105; Crescent Electronics). Measure-
ments were performed, and data were analyzed using the
WinWCP software (V4.9.1. Whole Cell Electrophysiology
Analysis Program, John Dempster, University of Strath-
clyde). All experiments were performed at room temperature.
Global gene expression analysis
by next-generation sequencing
Cells from a 6 cm culture dish were harvested by re-
suspension in 500mL TRIzol (Invitrogen), and total RNA
was extracted with the TRIzol method following the man-
ufacturer’s protocol. RNA was quality controlled by the
nanodrop and bioanalyzer. High-quality RNA (RIN > 9 and
260/230 > 2; 260/280> 1.8) was converted to cDNA and
Illumina-compatible sequencing libraries using NuGEN
Ovation and Encore NGS kits. Barcoded libraries were
pooled and sequenced on an Illumina Genome Analyzer
GAIIx in the single read mode with 80 nt read length. Reads
were mapped to the mouse genome using TopHat [15].
Differentially expressed genes between wild-type and
rybp-/- ESCs were identified with DESeq and filtered for
having a fold change >1.5 or < - 1.5 and fdr <0.05. In the
case of increasing gene expression, the fold change value
was calculated by the expression ratio of the rybp-/ - and the
wild-type samples; however, when the gene expression
showed a decreasing tendency, the negative reciprocal of
this quotient was used for the fold change calculation.
Significant genes were uploaded to the Ingenuity Pathway
Analysis (IPA) (www.ingenuity.com) platform, where func-
tional enrichment studies were executed. The extent of over-
representation was quantified by the Benjamini–Hochberg
corrected significance value that was calculated by using the
Fisher’s Exact test. Gene annotation information was either
derived from the knowledge base of IPA or collected from the
Ensembl database using the BioMart tool.
Results
Rybp is abundantly expressed in the developing
mouse heart
To gain further support for the presence of Rybp in dif-
ferent organs besides CNS, we examined the distribution of
rybp mRNAs by Northern blotting analysis using total RNA
isolated from multiple mouse tissues. Our results demon-
strated that the major 4.7 kb isoform of rybp is highly ex-
pressed in the heart and also in other mouse tissues (kidney,
liver, skin, small intestine, thymus) (Fig. 1A). To confirm
that Rybp is also present at the protein level in the devel-
oping mouse heart, we examined its expression pattern by
utilizing anti-Rybp (anti-Dedaf) antibody on embryonic
sections. Rybp was shown to be readily detectable in the
developing heart from day 8.5 of embryonic development
(E8.5) (Fig. 1B). Prominent Rybp expression persisted
during all embryonic stages examined and Rybp marked
differentiated cell types of the heart, suggesting its in-
volvement in heart development and differentiation.
rybp null ESCs do not form rhythmically
beating CMCs
Abundant expression of Rybp in the heart prompted us to
investigate the role of Rybp in the regulation of cardiac
lineage commitment. To investigate the function of Rybp
during cardiac differentiation, we utilized rybp null (rybp-/- )
ESCs lacking functional Rybp protein product [6] (Fig. 1C).
Rybp-/ - ESCs are viable and display typical ES cell mor-
phology when grown on an MEF monolayer, forming round
and oval-shaped compact colonies, indistinguishable from
those that formed by the wild-type cells [6] (Fig. 1D). We
used the classic HD method to generate EBs as a common
intermediate during the in vitro differentiation of pluripotent
stem cells into CMCs (Fig. 2A and Materials and Methods).
Differentiation in brief, to induce ESC differentiation LIF,
was withdrawn from the culture medium and cells were kept
as HDs (800 cells/20 mL) to form EBs. Two days later, EBs
were transferred into a suspension culture system. At d4 of
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differentiation, the EBs were placed onto gelatin-coated
coverslips, one of each of the coverslips, and they were
grown for another 10 days. We subjected undifferentiated
(d0) and differentiated (d8 and d14) cell samples to analysis.
Both WT and rybp-/ - ESCs formed EBs and attached to the
gelatin-coated surface of the dishes, and WT ESCs formed
rhythmically beating CMCs in 6–14 days (Fig. 2B). We
found that although EBs could be derived from the rybp null
ESCs no beating colonies were observed from the mutant
cells (Fig. 2B). Out of 400 WT EBs, 93% formed beating
CMCs when they were allowed to attach on gelatin-coated
surfaces by the 14th day of differentiation while none was
beating from the rybp-/- genotype. Studies using Fluo-4
Ca2 + -sensitive dye confirmed that rybp-/ - CMCs cannot
produce intracellular [Ca2 + ] transient, indicating that the
defective Ca handling may contribute to the loss of cell
shortening (Fig. 2C). Analysis of gross morphology of de-
rived CMCs showed decreased colony size and less cell
content in the rybp null ESCs than the wild type at each
examined timepoints of in vitro cardiac differentiation (Fig.
2D). This suggested that in vitro cardiac differentiation was
affected by the absence of functional rybp.
Ascorbic acid fails to induce contractility
of the rybp-/ - CMCs
Ascorbic acid (ASC) is a known inducer of cardiac dif-
ferentiation and robustly enhances cardiac differentiation of
even cell lines without spontaneous cardiogenic potential.
Therefore, we have added ASC supplement in the differen-
tiation medium of the rybp null mutant cells to test whether
their cardiogenic potential can be further increased in the
FIG. 1. Rybp is abundantly expressed in the embryonic and adult mouse heart. (A) Northern blot analysis with rybp-
specific probe identifies a 4.7 kb major transcript in various mouse tissues and a 0.6 kb mRNA transcript expressed
abundantly only in testis. Several rybp isoforms at lower-molecular-weight range (0.6–0.8 kb) are also visible in multiple
tissues (kidney, liver, skin, small intestine thymus). The smallest molecular weight 0.6 kb isoform is not present in the heart
and the brain. A 2.5 kb transcript is only present in the small intestine. (B) Representative examples of immunohisto-
chemistry performed with an anti-Rybp (anti-Dedaf; Chemicon) antibody (dark gray staining, arrows) on counterstained
(light gray) sections from early postimplantation developmental stages (E8.5; E9.5) in normal mouse embryos showing
Rybp expression in the heart. (C) Immunostaining of wild-type (rybp+/+ ) and rybp-/ - ESCs for Rybp. ESCs were fixed and
immunostained with anti-Dedaf antibody (light gray) and DAPI (dark gray). Rybp null ESCs are not expressing Rybp.
Magnification: 20· . (D) Bright field images of undifferentiated wild-type and rybp-null ESC colonies. Rybp null ESCs are
viable and display a typical ES cell morphology. Colonies are composed of small cells attached to each other with a high N/C
(nucleoplasm/cytoplasm) ratio where a single cytoplasm is not detectable. Based on gross morphology, the rybp-/ - ESCs
show the typical mouse ES cell morphology. Cells were grown on the MEF layer. Scale bar = 100mm. ESCs, embryonic
stem cells; MEF, mouse embryonic fibroblast; Rybp, Ring1 and Yy1 binding protein.
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presence of ASC. We found that ASC was not able to induce
the contractility of the rybp-/- derivatives any further.
However, as a result of the ASC treatment, cell populations
from both genotypes grew and formed bigger colonies with
visibly more cell layers than without ASC (Fig. 2D). This
suggested that the rybp nullmutant cells cannot form beating
CMCs either spontaneously or after induction by ASC.
Lack of Rybp affects Isl1, Tnnt2, and Tbx3
expression in CMCs
To gain insights into underlying molecular events, we
have measured the expression of lineage-specific markers in
the rybp-/ - ESCs and compared them with the WT cells.
We have also measured marker gene expression during the
FIG. 2. The rybp+/+ and rybp-/ -
ESC lines show differences in
morphology of differentiated CMC
colonies and in contractile activity.
(A) Schematic representation of in
vitro cardiac differentiation. CMCs
were differentiated in vitro from
ESCs by using the hanging-drop
method. CMC colonies were grown
for 21 days and sampled at differ-
ent time points (eg, day 0, 7, 14 and
21) as further required. (B) Quan-
titative analysis of beating CMC
colonies derived from rybp+/+ and
rybp-/- ESCs. Vertical axis indi-
cates the percentage of beating
colonies; horizontal axis shows the
days of observation (day 8, 11, 17
and 21). Day 0 corresponds to the
undifferentiated ES cell stage (no
beating). Ninety-three percent of
rybp+/+ CMC colonies were beat-
ing from day 8, and rybp-/ - CMC
colonies showed weak contractile
activity only at day 17 (*5%) and
day 21 (*20%). (C) Original re-
cordings from 12 days old beating
rybp+/+ and nonbeating rybp-/ -
CMCs derived from mouse ESCs.
Left panel shows the changes of
intracellular Ca2 + concentration as
a Ca2 + -dependent fluorescent sig-
nal (F535 nm). Right panel shows
the corresponding cell shortening.
(D) Comparison of rybp+/ + and
rybp-/- CMC morphology with
and without ASC treatment at day 7
and 14 shows prominent differ-
ences. The CMCs derived from WT
(rybp+/+ ) ESC line had grown in
multiple layers, while the mutant
(rybp-/- ) colonies were scattered
and thin. CMCs derived from both
ESC lines formed larger and more
developed colonies with ASC in-
duction. ASC, ascorbic acid; CMC,
cardiomyocyte; WT, wild type.
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time course of cardiac differentiation (d2, 4, 8, 10, 14) in
both genotypes. Analysis revealed no significant changes in
gene expression level of the key pluripotency genes (Rex1,
Oct4, Nanog) (Fig. 3) and pan-mesodermal markers (T/Bra,
Gsc) (Fig. 3). The expression of all examined pluripotency
markers was progressively downregulated in both cell
populations by differentiation. This suggested that silencing
of pluripotency gene expression was properly executed in
the rybp-/- cells as well. Importantly, further gene expres-
sion analysis revealed downregulation of the terminal car-
diogenic marker cardiac troponinT (Tnnt2) in the mutants,
suggesting that cardiac lineage commitment was impaired in
FIG. 3. rybp-deficient ESCs are impaired in cardiac differentiation and expression of pluripotency (Rex1, Oct4, Nanog),
early mesodermal (Bra, Gsc), early cardiac (Isl1, Gata4, Gata6), T-box (Tbx3, Tbx5), and PcG (Jmj, Eed, Ezh2) genes
during in vitro cardiac differentiation. For quantitative real-time polymerase chain reaction (RT-PCR) analyses, RNA was
extracted, reverse transcribed from differentiated cardiac cells generated from WT and rybp-/- ESCs at day 0, 2, 4, 8, 10,
and 14 of differentiation, and analyzed for expression of marker genes. Gapdh transcripts were amplified as an internal
control. The expressions of the indicated markers were relative gene expression changes and were normalized to Gapdh
expression. Quantitative RT-PCR was performed with the primers listed in Supplementary Table S1. Values and
means: – SD *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; *****P < 0.00001 (n = 5) Statistical method: t-test type 3.
PcG, polycomb group protein.
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the rybp-/ - cells. By examining the earlier steps of cardiac
lineage commitment (Isl1, Gata4, Gata6 expression), we
found no significant differences in the expression of Gata4
and Gata6 expression (Fig. 3) while Isl1 expression was
impaired in the mutants (near 6 ·more in the WT cells) (Fig.
3). Isl1 is a homeobox transcription factor and an essential
regulator of cardiac progenitor differentiation. Rybp may
function as a member of PRC1 [4,16] and regulate the ex-
pression of homeobox-type transcription factors during heart
development. Therefore, we have also examined whether
the expressions of the T-box (homeobox-type) cardiac
transcription factors (Tbx3, Tbx5) were changed. CMCs
lacking rybp showed more than a 2-fold increase in Tbx3
expression compared with WT (Fig. 3); however, the level
of Tbx5 did not change significantly. Together, the data
suggested that while expression of pluripotency genes was
commonly downregulated, differentiation-driven activation
of some cardiac transcription factors, such as the homeobox-
type Isl1 and Tbx3, is different between cells expressing
Rybp and those lacking Rybp.
Polycomb-repressive complex 2 (PRC2) regulates the
balance between self-renewal and differentiation of ESCs.
Therefore, we have examined whether loss of rybp results in
the altered expression of PRC2 members. Our data showed
no significant alterations in PcG expression levels, including
Ezh2, Eed, and also PCR2 regulator Jmj. This suggests that
lack of rybp (Fig. 3) has no significant influence on the
expression level of the PRC2 members. These results also
showed that Rybp is necessary for the proper execution of
CMC differentiation.
Transcriptome analysis reveals a spectrum
of genes with altered expression profile in the rybp
null ESCs and CMCs
To examine possible gene expression alterations in a
broader spectrum and to examine which signaling pathways
are influenced by the lack of rybp, we have performed a
quantitative comparative transcriptome analysis with the
Illumina genome analyzer. We have compared the gene
expression profile of the undifferentiated rybp-/- and WT
ESCs (d0). We also performed analysis on differentiated
ESCs (d8, d14). D8 represents an earlier time point and d14
corresponds to a later time point of in vitro cardiac differ-
entiation and lineage commitment. Using the filtering cri-
teria of a two-or-greater fold change in expression and a
false discovery rate of less than 1%, 53 out of more than
20747 transcripts were differentially expressed at the un-
differentiated stage (d0) (Table 1). At the differentiated
stage 3%, 716 out of more than 23045 transcripts were at d8
(early stage) (Table 1) and 3.5%, 768 out of more than
21982 transcripts were at d14 (late stage) (Table 1). Under
these conditions, there were 25 transcripts with increased
expression in the rybp null ESCs (d0), while 30 transcripts
showed decreased expression (Supplementary Tables S2 and
S3). There were 393 transcripts with increased expression in
the rybp null ESCs at d8, while 325 transcripts showed
decreased expression (Supplementary Tables S2 and S3). At
d14 of cardiac differentiation, 478 transcripts showed in-
creased expression and 292 showed decreased expression
(Supplementary Tables S2 and S3). To identify the biolog-
ical processes in which genes transcriptionally affected in
rybp-/- ESCs are involved, we performed gene function
enrichment analysis using the IPA knowledge base. At the
undifferentiated stage (d0), ESCs displayed the most strik-
ing effect that was recorded in genes that were critical for
germ development. The transcriptome analysis revealed that
genes critical for germ development were de-repressed in
comparison to the WT ESCs (eg, Tex11, Tex13, Piwil2,
Dazl, Rnf17) (Supplementary Tables S2 and S3). These
genes are involved in the early stage of spermatogenesis and
are also expressed in primordial germ cells. Immunostaining
of adult testis confirmed that Rybp was localized in sper-
matogonia and weak staining of spermatocytes, but it was
not visible in spermatids or Sertoli or Leydig cells (Sup-
plementary Fig. S1). The transcriptome analysis of d8 and
d14 differentiated cells showed that other genes, involved in
the later stage of sperm development, are also de-repressed
(eg, Ddx4, Mael, Syce1, Sycp3). The IPA analysis revealed
a significant enrichment in different Gene Ontology Biolo-
gical Process categories, such as apoptosis (d8: Supple-
mentary Table S4; d14 Supplementary Table S5) in which
rybp is already known to be involved [17,18]. This obser-
vation suggests that rybp deficiency has an effect on the
transcriptome in ESCs, which is consistent with the data
obtained.
Altered expression level of genes important
for cardiovascular system development
and function in the rybp-deficient CMCs
To better understand the precise role of rybp in heart
development, we conducted functional enrichment assay
using IPA. The IPA analyses revealed that several cardio-
vascular-related gene sets can be found among most over-
represented physiological functions in the rybp-deficient
samples during cardiac differentiation (d8: Fig. 4A, day 14:
Fig. 4B). Genes of this functional category with significantly
different expression in WT and rybp-/ - ESCs are listed in
Supplementary Table S6 (d8) and Supplementary Table S7
(d14). Given these data, which provided additional evidence
that absence of rybp has an effect on the transcriptome in
ESCs and CMCs, we further analyzed the data obtained by
DNA-seq and searched for genes expressed in the heart and
for genes already known to have a cardiac phenotype in
mouse models. One of the most downregulated genes
expressed during cardiac differentiation is Plagl1 (d0: FC =
- 13.86, padj = 2.3 · 10 - 5; d8: FC = - 76.79, padj = 3.44·
10-77; d14: FC= -92.91, padj=2.68·10-79; Supplementary
Table S3). Plagl1 is an essential factor for cardiac mor-
phogenesis and is highly expressed in mouse hearts from
E8.5 to adulthood in a chamber-restricted pattern. In the
rybp null ESCs, Plagl1 is nearly absent at all timepoints of
Table 1. Gene Expression Changes in rybp-/ - Cells
Significant
increase
Significant
decrease
Genes
detected
d0 24 29 20747
d8 392 324 23045
d14 477 291 21982
d, day.
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cardiac differentiation. On the contrary, one of the most
upregulated gene during cardiac differentiation was Tbx3
(d0: FC= 4.63, padj = 5.95 · 10 - 3; d8: FC= 3.07, padj =
5.53 · 10- 7; d14: FC = 3.53, padj = 2.11 · 10 - 6 Supple-
mentary Table S2), which is required for pacemaker and
conduction system development in the mammalian heart.
Tbx3 was present nearly 5 · higher in the rybp mutants
ESCs compared with the WT (d0) and was induced nearly
4 · and 5 · more in CMCs during cardiac differentia-
tion. Six1, which functions in cardiac progenitor cells but is
FIG. 4. (A–B) Functional categories overrepresented among genes with significantly different expression in WT and
rybp-/- ESCs. Vertical axis indicates the negative log10 transformed significance value of the enrichment calculated by
Fisher’s Exact Test. The horizontal (intermitted) line shows the P= 0.05 threshold generally accepted as the criterion for the
selection of significant enrichments. (A): samples from day 8. (B): samples from day 14. (C) Immunocytochemical
localization of the cardiac Tnnt2 protein (light gray) in rybp+/+ and rybp-/- CMCs. Immunofluorescence analysis of CMCs
derived from wild-type (rybp+/+ ) and null mutant (rybp-/- ) ESCs at day 21 of differentiation using an anti-cardiac troponin
T antibody reveals downregulation of cardiac troponinT (Tnnt2) in the mutants. Scale bar: 100mm; Objective: 20 · . (D)
Semi-quantification of Tnnt2 levels of (C) by using Olympus FluoView software. Means are standard deviation – SD.
Values of P< 0.05 were accepted as significant (***P < 0.001). Statistical method: t-test type 3.
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stably silenced on cardiac differentiation, was also under-
represented in the rybp null ESCs (d0) and CMCs (d8; d14)
(d0: FC= 75.00, padj = 1.74 · 10 - 2; d8: FC = -5.23, padj =
5.73 · 10- 1; d14: FC = - 2.45, padj = 9.48 · 10 - 1) [19]. Our
DNA-Seq data indicate that key cardiac differentiation
pathways are impaired in the rybp null cells. This suggested
that altered Rybp dosage led to the improper execution of
the cardiac developmental program.
Rybp-deficient ESCs do not express structural
genes that are essential for contractility
of matured CMSc
The observation that rybp-/- CMCs cannot form rhyth-
mically beating CMCs motivated us to perform gene func-
tion enrichment analysis using the IPA knowledge base and
to examine the expression level of genes that are important
for CMC contractility. IPA analysis revealed that rybp-/-
CMCs have an almost complete lack of organized myofibrils
and Z-line genes (eg, Actn1, Myh6, Myh7, Myl2, Myl3,
Myl4, Myod, Myom1, Tnni1, Tnni2, Tnni3, Tnnt2) when
compared with normal WT CMCs (Supplementary Table
S8). Among these genes, Tnnt2 is a key component of the
troponin complex in CMCs. It has a regulatory role in
CMC contraction by anchoring troponinI and troponinC to
tropomyosin on the thin filaments in the sarcomeres and
also confers a Ca2 + dependence on sarcomere contraction.
Since the rybp-/ - CMCs exhibit deficiency in terminal
differentiation marker Tnnt2 mRNA induction, we analyzed
the spatial distribution of the Tnnt2 protein product as well
(Fig. 4C). Immunostaining of late-stage CMCs (d21) con-
firmed that cardiac Tnnt2 is localized in the cytoplasm and
exhibits strong staining in the wild-type CMCs and its
presence is less prominent in the rybp-/- cells (Fig. 4C, D).
These data demonstrate that the absence of Rybp interferes
with the normal expression of structural genes that are im-
portant for contractility, and it may have an important role
in regulating CMC contraction and heartbeat.
Rybp-deficient ESCs can be partially rescued
by ectopic rybp
Having shown that lack of rybp led to an impaired dif-
ferentiation and interferes with CMC contractility, we as-
sessed whether ectopic expression of Rybp might rescue the
cardiac phenotype (no rhythmically contracting CMCs,
impaired cardiac gene expression profile) of the rybp-/-
cells. We have postulated that by re-introducing rybp with a
lentiviral expression vector (rescued cells; rybpRes) we can
possibly induce contraction and restore the gene expression
profile in the rescued cells (Fig. 2C).
We re-introduced the rybp cDNA in the rybp-/ - ESCs by
the lentiviral expression system (Fig. 5A). To this purpose,
we generated stable ESC clones expressing the HA-tagged
rybp cDNA in rybp-/ - ESCs (rybpRes ESC lines) and tested
for Rybp expression by immunohistochemistry (Fig. 5D)
and western blotting (Fig. 5B). Lower Rybp expression was
detected in the rybpRes lines compared with WT ESCs by
western blot analysis. To see whether this lower protein
expression was due to the insufficiency of our lentiviral
expression system, we performed quantitative RT-PCR
analysis of rybp mRNA in the rybpRes lines. We found 10–
15 times higher expression of rybp mRNA in the rybpRes
lines compared with WT ESCs (Fig. 5C).
To determine whether this level of Rypb was functional,
both rybp-/ - and two independent rescued ESC lines
(rybpRes1; rybpRes2) were allowed to differentiate toward
CMCs. As the results showed, increased spontaneous beat-
ing activity in 20%–25% of the rescued CMCs (rybpRes1;
rybpRes2) was observed (Fig. 5E). Microscopic observations
revealed an increased cellularity in the rybpRes clones
compared with the parental rybp-/ - cells (Fig. 5F). Mole-
cular analysis of the gene expression profile confirmed that
ectopic Rybp was able to partially rescue the cardiac defect:
Isl1, Tnnti3, and Myh6 expression was partially restored
(Fig. 5G). Furthermore, germ line-specific Tex11, Ddx4,
and Piwil2 expression was downregulated in rybpRes lines,
suggesting that Rybp is a repressor of germ-specific genes
and absence of Rybp leads to activation of these promoters.
This experiment also showed that a normal dosage of Rybp
is required for both activation (some of the cardiac) and
repression (germ specific) of target genes.
Discussion
We have previously shown the correct dose of Rybp re-
quired for maintaining the appropriate spatiotemporal ex-
pression pattern and levels of Rybp for proper CNS
development, thereby providing an in vivo mouse model of
NTDs [6]. In this study, we provided evidence for the ex-
pression of Rybp during mouse heart development and an-
alyzed the consequences of the loss of rybp on in vitro
cardiac differentiation. We found that homozygous rybp-
deficient ESCs formed cell clusters but were not able to
differentiate into rhythmically beating CMCs in vitro, sug-
gesting the requirement of rybp for proper cardiac dif-
ferentiation and contractility. Gene expression analysis of
undifferentiated ESCs and CMCs during cardiac differentiation
FIG. 5. Reconstitution of Rybp expression and function in rybp-/- ESCs. (A) Lentiviral construct used for ectopic
expression of Rybp. (B)Western blot analysis of WT, rybp-/- , and two independent rescued ESC lines (rybpRes1; rybpRes2).
Western blot was probed with anti-Dedaf antibody (38 kDa). (C) Quantitative RT-PCR analysis of rybpRes clones compared
with WT cells. (D) Immunostaining of WT, rybp-/ - , and rybpRes ESC clones for Rybp expression. ESCs were fixed and
immunostained with anti-Dedaf antibody. (E) Spontaneous beating activity of differentiated WT, rybp-/ - , and rescued ESC
lines (rybpRes1; rybpRes2). Beating of differentiated EBs was counted at day 0, 8, and 11 of differentiation. (F) Microscopic
analysis of cellularity of differentiated WT, rybp-/- , and rescued ESC lines (rybpRes1; rybpRes2). (G) Quantitative RT-PCR
analysis of cardiac- and germ cell-specific differentiation markers. RNA was extracted, reverse transcribed from differ-
entiated cardiac cells generated from WT, rybp-/- , and rescued ESC lines (rybpRes1; rybpRes2) at day 0, 4, 8, and 14 of
differentiation, and analyzed for expression of differentiation markers Isl1, Tnni3, Myh6, Tex11, Ddx4, and Piwil2. Gapdh
transcripts were amplified as an internal control. Values and means: – SD *P< 0.05; **P < 0.01; ***P < 0.001;
****P< 0.0001; (n = 5) Statistical method: t-test type 3. EBs, embryoid bodies.
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demonstrated upregulation (Tbx3) and downregulation of
several transcription factors (Isl1, Plagl1) and structural
myofibril proteins (Actn1, Myh6, Myh7, Myl2, Myl3, Myl4,
Myocd, Myom1, Tnni1, Tnni2, Tnni3, Tnnt2) that are
critical for heart development.
Aiming at finding the causatives of the observed pheno-
type, we have analyzed whether an alteration in pluri-
potency, or key developmental and cardiac gene expression
is responsible for the impairment. One possible explanation
for the impaired cardiac differentiation of the mutants is that
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pluripotency gene silencing is incomplete during differen-
tiation, which may cause impaired differentiation. First, we
analyzed the key pluripotency gene (eg, Rex1, Oct4, Nanog)
expression levels and we concluded that there were no
significant changes in the kinetics of pluripotency gene
expression between the two cell populations (rybp-/ - vs.
rybp+/ + ). We concluded that proper silencing of pluri-
potency genes shows the expected kinetics, thus it cannot be
the causative of the observed differentiation defect.
Second, since the mammalian heart essentially has a
mesodermal origin, we have tested whether the mesoderm is
properly formed in the rybp mutant cells. We did not find a
difference in the expression pattern of the pan-mesodermal
marker Bra/T, which, as expected, was nearly absent in the
undifferentiated ESCs and transiently expressed during EB
formation peaking at d4. Gsc, which is another marker or
early mesodermal lineage commitment, exhibited normal
expression pattern in the rybp mutants as well. Notably, the
level of Gsc transcripts was 3-fold higher in the undiffer-
entiated rybp-/- than in the wild-type ESCs, suggesting that
an abundant pool of mesodermal precursors is available in
the rybp-/ - cells at the beginning of cardiac differentiation.
Taken together, these data showed that silencing of pluri-
potency gene expression and formation of mesoderm were
comparable in both the WT and the rybp null mutant cells
and that the defect in cardiac differentiation is probably due
to later-stage causatives. By examining the induction kinetic
of several key cardiac transcription factors, we have found
that induction of Isl1 expression was defective in the
rybp-/ - cells (10· vs. 2 · by d8; 12 · vs. 5 · by d10) (Fig.
3). Isl1 is an essential regulator of cardiac progenitor dif-
ferentiation and also an important transcriptional factor for
the development of the secondary heart field. Thus, one
possible explanation for the phenotype is that deficiency in
Isl1 expression leads to improper cardiac progenitor cell
differentiation and these resulted in defects in producing
functional CMCs in the rybp-/ - mutants. It is also
worthwhile to note that Isl1 belongs to the family of
homeodomain transcriptional regulators, thus it can be a
potential target of Rybp by a PcG-dependent fashion. PcG
proteins regulate homeotic gene expression and are es-
sential for organ development. It had been previously
shown that members of the PRC1 and PRC2 complexes
have essential roles in early embryonic development;
however, few of their target genes are known in mammals
[20,21]. Some of the PcG proteins were also shown to have
an essential function in mammalian heart development. A
key cardiac regulatory gene, six1, which also has altered
expression in the rybp-/ - CMCs, is suppressed by a PcG-
mediated mechanism by PRC2 member Ezh2 and Eed in
cardiac differentiation [22]. Loss of Ezh2 in cardiac pro-
genitors and in CMCs mediated by early myocardial
transcription factor Nkx2.5Cre resulted in lethal heart ab-
normalities and disrupted CMC gene expression. PRC1
member Rae28 knockout mice displayed cardiac anomalies
similar to congenital heart diseases in humans [23]. Rae28
sustains Nkx2.5 expression in CMCs and plays a key role
in cardiac lineage commitment [24]. Furthermore, in ES
cell-based assays, the loss of function of the Rybp binding
partner Yy1 resulted in a decrease in CMCs, whereas Yy1
gain of function enhanced the generation of cardiac cells
[25]. As far as the potential role of Rybp in PRC-mediated
repression is concerned, we still do not have a clear un-
derstanding of how Rybp functions as a PRC member or
how PcG complexes containing Rybp reach their targets.
Rybp is generally considered a PcG protein and a tran-
scriptional repressor [5,26], so downregulation of down-
stream targets that results from the absence of rybp seems
paradoxical. This leads to two alternate possibilities. Either
Rybp normally represses factors that would otherwise re-
press the target genes (absence of a putative repressor re-
sults in the downregulation of downstream targets), or
Rybp functions as a transcriptional activator on some
genes. In the first case, we would expect that the repressive
function of Rybp is typical of a PRC1 complex-dependent
regulation. In the second case, activation by Rybp would
most likely be independent of PcG proteins although it is
also possible that Rybp specifically displaces PRC1 from
chromatin and facilitates transcriptional activation in this
manner [27]. By the biochemical characterization of Rybp
Containing Multimeric Protein Complexes, much of which
should also contain Ring1 or Yy1 proteins, this paradox
might be easier to solve.
On the other hand, lack of Rybp did not result in a sig-
nificant change in the expression level of some other
homeodomain transcription factors. The level of Tbx5,
which is an essential gene of mammalian heart develop-
ment, did not change in our experiments, suggesting that
Rybp regulates cardiac transcription factors via different
regulatory circuits. It has also been reported that Rybp is
functioning as member of the noncanonical PRC1 complex
in a broad variety of target genes [4]. Rybp, as a member of
the noncanonical PRC, has an emerging and complex role in
the regulation of gene expression, differentiation, and de-
velopment. Furthermore, Rybp defines functionally different
PRC1 family complexes, thus preventing the incorporation
of other canonical PRC1 subunits, such as Cbx, Scm, and
Phc. The precise biological functions of these versatile
complexes are not known [4]. To clarify whether Rybp is
functioning as a member of the PRC1 complexes during
heart development certainly needs further investigations.
Notably, transcriptome analysis did not show any distur-
bance in PcG protein distribution between the undifferen-
tiated rybp-/- and WT ESCs or CMCs (Supplementary
Tables S2 and S3). This suggests that the lack of functional
Rybp had no significant effect on the expression of the
PRC1 and PRC2 members.
Downregulation of terminal cardiac marker Tnnt2 in the
rybp-/- CMCs may indicate the role of Rybp in regulating
structural proteins of the functional sarcomer. Lack of Tnnt2
in mouse models caused early embryonic lethality due to a
lack of heartbeats [28]. Our gene expression analysis
showed decreased expression of Tnnt2 in the rybp null
mutants (*2,000· vs. 500· by d8; 3,000 · vs. 500 · by d10
and 3,500 · vs. 500 · by d14); however, it was still abun-
dantly expressed even in the rybp-/ - mutant CMCs (500·)
compared with the WT CMCs (Fig. 3). This suggests that
perhaps not only the availability but also the functionality of
Tnnt2 is critical for the contraction of the WT CMCs.
Members of PRC2 are also required later in heart develop-
ment, as demonstrated by the conditional TNT-Cre in-
activated Eed knockout mice. However, Ezh2 inactivation
(another essential member of PRC2) by TNT-Cre did not
cause an overt phenotype, likely because of functional
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redundancy with Ezh1 [22]. Further experiments need to
clarify whether the assembly of functional sarcomeres is
impaired in the rybp mutants.
Our recent study also showed that the defect in contrac-
tility in the rybp null CMCs could not be restored by adding
ASC to the culture as a supplement. ASC has multiple ef-
fects on cell proliferation and differentiation, especially of
promoting mesenchymal cells toward adipogenesis, osteo-
genesis, chondrogenesis, and myogenesis. ASC is also able
to restore the contractile response in patients after heart
failure or myocardial infarction [29]. However, in our ex-
periments, ASC was not able to restore contractility of the
mutant CMCs but increased the cell mass of the rybp-/ - and
rybp+/+ CMCs. Little is known about the exact effect of
ASC, but it has been reported that reactive oxygen species
(ROS) regulate the intracellular signal transduction of the b-
adrenergic pathway, that is, its receptors, G-proteins and
adenylyl cyclase, function in the myocardium [30]. These
observations have led to the hypothesis that ROS directly
affect myocardial contractile function through alteration of
the b-adrenergic pathway. Future experiments need to
clarify whether members of the b-adrenergic pathway are
defective in the rybp-/- CMCs.
Importantly, re-introduction of rybp by a lentiviral ex-
pression vector in rybp deficient ESCs was able to rescue
the mutant phenotype and has partially restored contractility
of the rybp-/- CMCs. The appearance of contracting cells
was paralleled by the expression of early (Isl1) and late
(Tnni3) cardiac gene markers, thus suggesting their identity
as CMCs.
It is also important to mention that the absence of func-
tional Rybp had a significant effect on the cascade members
of germ cell development. This is in agreement with the
abundant expression of Rybp in the reproductive systems
and the recent observation of Hisada et al., that Rybp
functions as a de-repressor of germ specific genes in plu-
ripotent ESCs [31]. Our transcriptome analysis revealed that
abundant expression of germ line-specific genes persists
during the entire course of in vitro cardiac differentiation
and their downregulation is impaired. Our experiments
demonstrated that abundant germ line-specific gene ex-
pression persists during the entire time course of cardiac
differentiation in the mutants. Therefore, we cannot rule out
the possible effect of this abundant germ-specific gene ex-
pression on the inhibition of normal somatic differentiation
(eg, cardiac), which needs further investigation. Especially,
recent evidence indicates that germ line-specific genes [eg,
vasa (Ddx4), stella (Dppa3)] also function in other cell
types, distinct from the germ line or in facilitating differ-
entiation toward endodermal lineage commitment [32,33].
Both genes, Ddx4 and Dppa3, are aberrantly upregulated in
our rybp-deficient ESCs and Ddx4 is expressed throughout
cardiac-derived differentiation in rybp-/- CMCs. In our
experiments, forced expression of exogenous Rybp partially
restored the repressed state of genes that is important for
normal germ cell development in the rybp-deficient ESCs.
This underlines the function of Rybp in epigenetic regula-
tion at early-stage embryonic development [31] and pin-
points the importance of germ line gene silencing during
somatic differentiation.
In summary, we demonstrate, for the first time, that the
differentiation capacity of ESCs that lack rybp toward the
cardiogenic cell fate is severely impaired. We find that rybp
null ESCs are blocked in cardiac differentiation. Finally, we
present evidence that Rybp contributes to the contractility of
CMCs during stem cell differentiation.
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